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Abstract
The lytic cycle of phage Mu is regulated by a transcriptional cascade consisting of 
early, middle and late transcription. The Mor protein is an activator of the middle 
promoter Pm and is encoded by the last gene of the early transcript. The C protein is an 
activator of the four late promoters Plys, PI, PP, and Pmom and is expressed from the middle 
transcript. Both Mor and C proteins bind an imperfect dyad-symmetry element just 
upstream and overlapping the –35 region of Pm and Plys respectively. The main aims of 
this study was, (1) To understand the binding specificity of C and determine a possible 
consensus sequence for C binding, and (2) To crystallize the C : DNA complex as a first 
step towards structure determination. 
In previous work, single base substitution mutations in Plys identified bases and 
positions important for C binding and activation. To get a consensus sequence for C 
binding, we tested additional candidate mutations within and flanking the C binding 
sequence. Wild-type C protein was used in gel mobility shift assays with annealed 
oligonucleotides containing mutations, insertions and deletions. The assay showed that, 
(1) mutation in positions –53, –52 and –32 did not affect C binding, (2) mutations 
flanking the IR spacer (–40, –41, –46, –47) influence C binding, and (3) insertion or 
deletion of a single base pair in the IR spacer abolished C binding. 
Mor and C proteins are the founding members of a new class of transcription 
factors. The Mor structure revealed that it has a classical DNA-binding HTH motif and a 
dimerization domain. Based on the structure it has been proposed that Mor has to 
undergo conformational changes to bind DNA. Modelling of C based on the Mor  
 v 
  
 
structure revealed that C might also have a dimerization domain and a HTH DNA 
binding motif. To see if any conformational changes occur in C when it binds DNA, co-
crystallization of a C : DNA complex was undertaken. Preliminary structural analysis of 
the complex revealed that under the crystallization conditions used C protein is bound to 
its symmetrical binding site using two HTH motifs from two C dimers without inducing 
any conformational change in itself or the DNA.  
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 Chapter 1. Introduction 
Gene expression is one of the important classes in the central dogma of molecular 
biology. In gene expression, the information from the DNA coding region is converted 
into a functional protein in a multi-step process. Transcription is the first step in gene 
expression in which the information in the DNA is transcribed by DNA-dependent RNA 
polymerase (RNAP) into messenger RNA (mRNA). The mRNA is then translated by the 
ribosomes to produce polypeptides. This process can be regulated or modulated in each 
step, giving the cell or the organism a control over its morphology, differentiation and 
function.  
 
An overview of transcription 
Transcription proceeds in the 5′ to 3′ direction using the DNA as template and is 
divided into three sequential stages; initiation, elongation and termination. Transcription 
initiation is a multi-step process characterized by binding of the sigma (σ) subunit of the 
RNAP holoenzyme to the promoter (P) to form a closed binary complex (RPc). 
Subsequent melting of the DNA strands along with a conformational change in the 
RNAP leads to the formation of an open complex (RPo). Formation of RPc and RPo are 
rate-limiting steps that can be modulated by activators and repressors. RPo in the 
presence of the four nucleotide triphosphates proceeds to an initiated complex (RP init) 
which can be engaged in an iterative abortive initiation process, generating and releasing 
short nascent RNA chains less than 10 nt long. Abortive initiation terminates and 
initiation is complete when RNAP breaks contacts with the promoter, releases the σ 
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subunit, and escapes as a productive elongation complex.  Termination of transcription 
may occur when (1) the RNAP encounters a transcription terminator involving formation 
of a mRNA hairpin and (2) by a protein called Rho, leading to a process called Rho-
dependent termination. Regulation of transcription is usually done by regulatory proteins, 
which can be (1) specificity factors (σ), (2) repressors and (3) activators. Regulation is 
only achieved when these regulatory proteins bind specific DNA sequences using 
different DNA-binding motifs. 
 
RNA polymerase 
In prokaryotes, two forms of RNAP are involved in transcription. One form of the 
RNAP, termed holoenzyme, is required for transcription initation and is specific to the 
promoters (Figure 1-1). The specificity is due to the σ subunit of the RNAP and is formed 
when σ binds the core.  The second form called the core RNAP (Figure 1-1) binds DNA 
nonspecifically since it lacks the σ subunit; is incapable of initiating transcription from 
the promoter but capable of elongating an RNA transcript. The core enzyme is composed 
of five subunits (α1, α2, β, β’, ω) with a combined molecular mass of ~ 400 kDa 
(Borukhov and Severinov, 2002).  
 
The sigma (σ) subunit 
Sigma is a DNA-binding specificity factor that recognizes the promoter upstream 
of the protein-coding region and is very important for transcription initiation (Darst et al., 
1998; Zhang et al., 1999; Tahirov et al., 2002). There are seven different species of the σ 
subunit identified in Escherichia coli (E.coli) (Gross et al., 1998; Helmann and  
 2 
  
 
  
 
 
 
 
Figure 1-1.  Domain organization of σ70 into various conserved regions with their 
identified functions. Reprinted with permission from Owens, J. T., Miyake, R., 
Murakami, K.,  Chmura, A.J.,  Fujita, N.,  Ishihama, A., and Meares. C.F.  (1998) 
Mapping the σ70subunit contact sites on Escherichia coli RNA polymerase with a σ70-
conjugated chemical protease PNAS 95: 6021-6026 
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Chamberlin, 1988; Ishihama, 1988). Each sigma is involved in transcription of a specific 
set of genes. Most of the housekeeping genes, which are expressed during the exponential 
growth phase, are transcribed by the holoenzyme containing σ70 (rpoD gene product), the 
principal sigma factor (Ishihama, 2000). The rpoH gene product σ32 is expressed when 
the bacterial cells are exposed to high temperatures in order to turn on transcription of 
genes required for surviving such temperatures. The rpoS gene product σS is expressed 
when the bacterial cells are in stationary phase. The rpoF gene product σF is expressed to 
turn on genes involved in flagellum synthesis. The rpoE gene product σE is expressed 
during heat shock, oxidative stress and for expression of extracytoplasmic proteins. The 
fecI gene product σFecI regulates the fec genes for iron dicitrate transport. The rpoN gene 
product σ54 is a distinct class of sigma, which is structurally and chemically different 
from members of the σ70 family. This sigma is present at all times in the bacterial cell and 
is important for turning on genes involved in nitrogen regulation. There are four flexible 
domains in σ70 referred to as σ1.1, σ2, σ3 and σ4 (Helmann and Chamberlin, 1988) (Figure 
1-1). Each domain contains one or more highly conserved regions; 1.1 and 1.2, 2.1-2.4, 
3.1-3.2 and 4.1- 4.2 (Malhotra et al., 1996; Gross, 1998; Borukhov and Severinov, 2002; 
Campbell et al., 2002; Murakami et al., 2002; Vassylyev et al., 2002; Murakami and 
Darst, 2003). The σ70 makes sequence-specific contacts within the –10 hexamer 
(consensus TATAAT) and –35 hexamer (consensus TTGACA) of the promoter using 
region 2.4 and region 4.2 only when σ70 is bound to the core RNAP. The σ70 cannot bind 
the promoter on its own since region 1.1 masks region 2.4 and region 4.2; and binding 
inhibition is only released after sigma binds the core RNAP. The σ70 can also direct 
transcription from extended –10 promoters that do not have a good –35 hexamer 
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(Helmann and Chamberlin, 1988). Region 2.5 (not shown) makes supplementary contact 
with the extended  –10 motif (Barne et al., 1997). Region 4 is important for contacting 
the –35 hexamer and interacting with the α-CTD and transcription activators.  
 
The alpha (α) subunit 
The α subunit is made up of 329 amino-acids and is structurally divided into two 
independent domains (α-NTD and α-CTD). The α-NTD (28 kDa) plays an important 
role in assembling the RNAP by providing the contact surfaces for α dimerization and for 
binding the β and β′ subunits (Kimura et al., 1994; Kimura and Ishihama, 1995a, b, 1996) 
of the RNAP. A flexible linker made up of 13 amino-acids connects the α-NTD and α-
CTD. This long unstructured linker allows the α-CTD to occupy different positions 
relative to the α NTD and RNAP (Blatter et al., 1994; Busby and Ebright, 1994; Ebright 
and Busby, 1995). The α-CTD (8 kDa) plays a regulatory role by providing the contact 
surfaces for trans-acting regulatory protein factors and cis-acting DNA elements               
(Igarashi et al., 1991; Igarashi and Ishihama, 1991; Gaal et al., 1996; Murakami et al., 
1996). The α CTD binds the DNA minor groove upstream of the –35 hexamer using a 
helix-hairpin-helix (HhH) DNA binding motif (Jeon et al., 1995; Gaal et al., 1996; Shao 
and Grishin, 2000; Ross et al., 2001); this motif is called the 265 determinant (Gaal et al., 
1996; Murakami et al., 1996). The α-CTD interacts with various transcription factors 
using the 287 determinant, which is made up of eight different amino-acid residues.  
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The β and β′ subunits 
The core RNAP is made up of two α subunits, one β (150.6 kDa, rpoB gene 
product) and one β′ (155.2 kDa, rpoC gene product) subunit along with a smaller more-
loosely bound subunit called omega (ω). The β and β′ subunits are the two largest 
subunits of the RNAP and form a catalytic core around a chelated Mg2+ using conserved 
regions A to I in β and region A to H in β′ (Figure 1-2). The β subunit contacts α1 while 
β′  makes contacts with α2 (Zhang et al., 1999). The β and β′ subunits play a key role in 
transcription since they form the active site for polymerization and interact with 
activators, repressors, elongation factors and termination factors (Severinov et al., 1994; 
Sharp et al., 1999). The ω subunit is the smallest subunit and has a chaperone-like role in 
RNAP assembly (Mukherjee et al., 1998). 
 
 Overall structure of RNAP 
The bacterial RNAP holoenzyme structure has been solved from Thermus 
aquaticus and Thermus thermophilus (Murakami et al., 2002; Vassylyev et al., 2002). 
The core RNAP resembles the claw of a crab (Figure 1-2). The two sides of the claw are 
made up of β and β′, which also form the active site channel with a diameter of 27 Å. The 
entire length of the active-site channel is occupied by σ, and the negatively charged 
amino-acids of σ1.1 and σ3.2 occupy the upper and lower portions of the active-site 
channel, respectively (Mekler et al., 2002; Murakami et al., 2002; Vassylyev et al., 
2002). These charged amino-acids mask the positively-charged portion of the channel, 
thus narrowing the channel and preventing nonspecific binding of RNAP to DNA. 
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Figure 1-2.  Illustration of the σ70 subunit and RNA polymerase. The σ70 subunit is 
colored red, the β subunit is blue, and β′ is pink. (a) A diagrammatic representation of σ70 
depicting its conserved domain organization. (b) different forms of RNAP. Reprinted 
with permission from Hsu, L.M. (2002) Open season on RNA polymerase. Nat Struct 
Biol 9: 502-504. 
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Regions 2.4 and 4.2 of σ are solvent exposed and make specific contacts with the –10 and  
–35 hexamer of the promoter. Region 3.2 is a linker, connecting regions 3 and 4; it loops 
around the RNAP active-site channel and exits through the RNA-exit channel.  
  
 Promoter 
The consensus sequence for promoters from E. coli has a –10 (5’ TATAAT 3’) 
and  –35 hexamer (5’ TTGACA 3’) separated by a 16-18 bp spacer with 17 bp being the 
most optimal (Youderian et al., 1982; Harley and Reynolds, 1987; Helmann and 
Chamberlin, 1988; Lisser and Margalit, 1993). The hexamers are only contacted by the σ 
subunit of the RNAP holoenzyme (Thomas et al., 1996; Gross et al., 1998). In some 
promoters an AT-rich region known as the UP element is present just upstream of the –35 
hexamer; and this region contains two distinct subsites (proximal and distal), which are 
recognized by the α-CTD (Ross et al., 1993; Gaal et al., 1996; Estrem et al., 1998). The 
promoter strength is a function of the entire promoter, with very strong promoters like the 
rrnB promoter having sequences close to the consensus. The start point of transcription 
(+1) in E. coli promoters is occupied by a purine nucleotide, with ‘A’ preferred over ‘G’ 
in the vast majority of the characterized promoters. 
  There is an additional class of promoter known as the “extended  –10 promoter” 
in which the –35 recognition elements of σ are dispensable for transcription initiation.  
These promoters are distinguished by the presence of a new consensus sequence in the    
–10 region (TGnTATAAT) (Keilty and Rosenberg, 1987; Chan and Busby, 1989). 
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RNAP-activator interactions 
Transcription from most bacterial promoters can be modulated by regulatory 
proteins. In most cases regulatory proteins bind within or upstream of the core promoter 
and may have direct contact with RNAP. Transcription activation involves protein-
protein interactions or the presence of an activator protein in close proximity to the 
RNAP with an intact DNA duplex between the two binding sites (Kustu et al., 1991; 
Ebright, 1993). An important contact point in RNAP for these activator proteins is the α-
CTD. Based on the positioning of an activator protein on the promoter and contacts made 
by the α-CTD and σ-CTD the transcription complexes are classified as basal, UP 
element-dependent and activator dependent. These complexes are divided into Class 
I/II/III or mixed promoters (Busby and Ebright, 1994, 1999)  
 
 
Transcription initiation 
Transcription initiation is a complicated multi-step process that involves (1) 
promoter recognition by the RNAP to form a closed complex (2) formation of a 
competent initiation complex (open complex), followed by production of short abortive 
transcripts and (3) promoter clearance of RNAP as it enters the elongation phase. Due to 
the multiple steps involved, there are many targets for regulation. The sigma subunit of 
the RNAP holoenzyme recognizes the –10 and the –35 hexamers to form an inactive, 
unstable, closed complex (RPc) (Figure 1-3). The RPc extends from –55 to –10 in a 
sequence-specific manner in which the DNA is protected from DNAse and hydroxy 
radical cleavage by the holoenzyme (Pavletich and Pabo, 1991; Marmorstein et al., 1992; 
Fairall et al., 1993; Marmorstein and Harrison, 1994;. Raumann et al., 1994)  
 9 
  
 
 
Figure 1-3.  Diagrammatic representation of various stages in transcription initiation. (a) 
closed complex,  (b) intermediate complex,  (c) and (d) open complex leading to abortive 
initiation and subsequent ending of abortive initiation,  (e) promoter clearance, and (f) 
transcription elongation complex (TEC). Reprinted with permission from Murakami, 
K.S., and Darst, S.A. (2003) Bacterial RNA polymerases: the wholo story. Curr Opin 
Struct Biol 13: 31-39. 
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(Figure 1-3). The RPc is sensitive to the DNA mimic heparin that competes with DNA 
for RNAP binding The second step is the transition to an intermediate complex (Buc and 
McClure, 1985) (Figure 1-3). The intermediate complex is a stressed complex formed 
due to a change in the conformation of the RNAP and DNA. The –35 and –10 regions of 
the DNA are rotated relative to each other by untwisting of the spacer DNA followed by 
wrapping of the DNA around RNAP, a process called open complex formation (RPo) 
(Figure 1-3). The open complex is resistant to heparin and base pairs between positions   
–9 to +2 in the promoter DNA are opened uni-directionally to form the transcription 
bubble (Saucier and Wang, 1972; Kirkegaard et al., 1983). The template strand of the 
DNA is located near the active site of the RNAP and lies in the positively-charged active 
site channel (Fogh et al., 1994). Upon addition of nucleotide triphosphates the 
transcriptionally competent open complex RPo starts to synthesize the RNA. During this 
process the σ3.2 loop is present in the path of the extending RNA–DNA hybrid, which 
results in abortive initiation (Figure 1-3). This is a recurring process until the nascent 
RNA reaches a critical length of ~ten nucleotides. When the transcript is more than ten 
nucleotides, it is sufficiently long enough to exit from the RNA exit channel under the β 
flap, resulting in complete displacement of the σ3.2 loop. This displacement and the 
continuing RNA synthesis leads to destabilization of the σ4 interactions with the –35 
region, allowing RNAP to break free from the promoter. A stable transcription elongation 
complex (TEC) is formed with release of the sigma subunit (Figure 1-3). In most 
promoters, the presence of RNAP and transcription activators is sufficient for RPo 
formation, while in others the addition of NTPs or formation of the first phosphodiester 
bond is required (Newlands et al., 1991; Ohlsen and Gralla, 1992).   
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 Regulation of transcription
 
Regulation of transcription in prokaryotes is based on the environment detected 
by the cell. This regulation is mainly achieved by regulatory proteins called transcription 
factors, which may or may not interact directly with the RNAP. Depending upon their 
mode of action, the transcription factor can be either a repressor (negative regulator) or 
an activator (positive regulator) (Ptashne, 2004). To interact with the RNAP the 
regulatory protein should first bind to its cognate DNA binding site using one of many 
different DNA binding motifs. The most common motif is the helix-turn-helix (HTH), 
which was first, identified in Cap, Cro and λ repressor proteins using structural and 
sequence similarities (Matthews et al., 1982; Ohlendorf et al., 1982; Sauer et al., 1982; 
Steitz et al., 1982; Ohlendorf et al., 1983). In prokaryotes, this motif is commonly found 
in regulatory proteins (repressors and activators) and sigma factors (Landick et al., 1984; 
Yura et al., 1984; Gribskov and Burgess, 1986). In eukaryotes the HTH motif is seen in 
proteins that regulate development and differentiation, transcription factors  (TFIIB/ 
TFIIE) and chromatin proteins (histone H1) (Schultz et al., 1991; Wilson et al., 1992 
Brennan, 1993; Clark et al., 1993; Ramakrishnan et al., 1993; Swindells, 1995; 
Kodandapani et al., 1996; Aravind and Koonin, 1999; Gajiwala and Burley, 2000). This 
motif has also been identified in proteins involved in DNA repair and RNA metabolism   
(Moore et al., 1994; Wah et al., 1997; Selmer and Su, 2002; Alfano et al., 2004; Dong et 
al., 2004). In addition to DNA binding, the HTH can also be adapted for mediating 
specific protein-protein interactions or can be part of a structural unit of a large enzymatic 
domain (Guo et al., 1997; Wong et al., 2000; Zheng et al., 2002).  
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The HTH motif consists of three α helices (one, two and three), which are usually 
right, handed and interconnected to each other by linkers. Helix one is the scaffolding 
helix for positioning of helices two and three (recognition helix) which form the HTH 
motif, with the linker in between making a 120° turn (Figure 1-4). The linker is made up 
of three or four amino-acids and does not tolerate insertions or deletions, but the loop 
between helix one and helix two may vary depending upon which class of the HTH 
family the protein is in. The third helix “recognition helix” makes base- specific contacts 
in the major groove and forms the principal DNA-protein interface (Brennan and 
Matthews, 1989; Otting et al., 1990; Brennan, 1993).  
 There are several conserved features in the HTH fold, and the most distinct is the 
‘shs’ pattern (Aravind et al., 2005) in the turn between helix two and three. The ‘s’ 
denotes a small unbranched amino-acid like glycine and ’h’ denotes a hydrophobic 
residue. The other conserved feature called the ‘phs’ pattern is present in helix two in 
which ‘p’ is a charged residue. The core tri-helical bundle is stabilized by localization of 
hydrophobic interactions between conserved hydrophobic residues in helix one, two and 
three to form a distinct hydrophobic core (Figure 1-4). 
There are a number of variations to the classical HTH which may include (1) a 
longer turn with different angles with and without rearrangements of the three helix 
bundle (Assa-Munt et al., 1993; Clark et al., 1993; Donaldson et al., 1994; Fogh et al., 
1994; Harrison et al., 1994; Liang et al., 1994; Schumacher et al., 1994; Vuister et al., 
1994), (2) a different conformation as in the c-myb proto-oncogene (Ogata et al., 1992) 
and hepatocyte transcription factor 1fb1/hnf1 (Finney, 1990) and (3) topological variation 
in the HTH  in which the HTH may be completely alpha helical or beta strands may form  
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Figure 1-4.  Variations of the classical HTH motif. Reprinted with permission from 
Aravind, L., Anantharaman, V., Balaji, S., Babu, M.M., and Iyer, L.M. (2005) The many 
faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS 
Microbiol Rev 29: 231-262.  
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an antiparallel beta sheet which may interrupt the motif by preceding or following the 
helices involved in DNA binding (Brennan, 1993; Lai et al., 1993: Clubb et al., 1994). 
Based on the distinctive features the HTH-containing proteins can be classified into two 
major structural classes and a very distinct third class that has drastic alterations to the 
HTH core. 
In class I of the HTH-containing proteins in addition to the basic tri-helix there 
may be tight packing of the recognition helix by means of Zn++ as seen in the retroviral 
integrase (Figure 1-4) (Cai et al., 1997). In certain proteins such as AraC, TetR, TrpR, 
there is an additional C-terminal helix, which forms a tetra-helical version of the HTH 
motif (Figure 1-4). In some eukaryotic basal-transcription factors, the tetra-helical HTH 
is further modified to form a multi-helical HTH. There are also rare modifications of the 
basic tri-helix in which there are additional N-and C-terminal helices with different 
packing than that seen normally in tetra-helical forms, e.g. KorB-like HTH (Khare et al., 
2004) and Fihb-like HTH (Campos et al., 2001)  
 The class II HTH is mainly composed of the winged HTH (wHTH) as shown in 
Figure 1-4. The wHTH was based on the structure of the hepatocyte nuclear factor 
(HNF)3/forkhead DNA binding domain (Clark et al., 1993; Feng et al., 1994). In addition 
to the HTH, there are two beta-strand hairpins that make DNA backbone contacts. These 
hairpins follow the HTH region and provide additional charged residues to interact with 
the minor groove bases adjacent to the major groove (Brennan, 1993; Clark et al., 1993; 
Swindells, 1995). There are also several modifications of the beta sheet, which may 
include three-or four-strand versions (Figure 1-4). In prokaryotes, the two-or three-strand 
versions predominate. 
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 The third class of HTH includes proteins from both class I and II but the proteins 
are highly modified, as observed for the Met I - Arc family of transcription factors. This 
family is also referred to as the ribbon-helix-helix (RHH family). This RHH family is 
usually a dimer and has a C-terminal HTH which is similar to the canonical HTH 
(Gomis-Ruth et al., 1998). The N-terminal region forms a strand that is used for 
dimerization as well as making contacts in the DNA major groove (Gomis-Ruth et al., 
1998). One interesting aspect of the N-terminus is that a single mutation can convert the 
sheet to a helix, which then forms a motif similar to the conventional HTH. 
 In the wHTH of the bacterial transcription regulator MerR, helix one of the HTH 
motif is not present. The topoisomerase II family has two copies of the wHTH domain, 
and in one there is a beta sheet as well as a wHTH insertion between helix one and helix 
two; the beta sheet contacts the DNA by forming a brace around the DNA (Grishin, 
2000). The Oct1-Pou DNA complex consists of two DNA binding domains; (1) the Pou- 
specific domain in which the HTH is similar to that of the lambda repressor (Assa-Munt 
et al., 1993; Dekker et al., 1993) and (2) the Pou homeodomain which is similar to the 
eukaryotic homeodomain (Kissinger et al., 1990; Wolberger et al., 1991 Qian et al., 
1994). Both domains are tethered by only a linker (Klemm et al., 1994) with no other 
protein-protein interactions between them.  
The Hin recombinase protein contains an HTH motif as well as N-and C-terminal 
arms that contact the minor groove (Feng et al., 1994). The important difference is the 
position of the HTH, which is midway between that seen for the lambda repressor and the 
homeodomain. The N-terminal arm is similar to the HTH recognition arm since it makes 
base-specific contacts. The HTH motif of the PurR repressor is different from the 
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classical HTH because the PurR HTH motif is formed from helix one and two, with its 
orientation reversed. This orientation reversion is also seen in the solution structure of the 
LacI repressor bound to DNA as well as in the Tet repressor (Hinrichs et al., 1994). The  
PurR repressor also uses the fourth helix known as the ‘hinge helix’ to make base- 
specific interactions in the minor groove (Schumacher et al., 1994). Dimerization of the 
PurR monomer is facilitated by the hinge helix making hydrophobic interactions. 
 
 
X-ray crystallography
 
A complete understanding of biology will require three-dimensional (3D) 
structures of individual components as well as macromolecular complexes. Structures of 
biological macromolecules allow us to study how macromolecules interact with each 
other, what their mechanism of action is at the atomic level, and how the structure can be 
used for structure based-drug development (Smyth and Martin, 2000). Three dimensional 
structures are obtained from a wide array of techniques such as X-ray crystallography, 
nuclear magnetic resonance (NMR), cryo electron microscopy (CEM) and atomic force 
microscopy (AFM) to name a few. 
X-ray crystallography is often used to obtain detailed information on the structure 
and function of biological molecules. In bio-molecular X-ray crystallography, the first 
step is to purify the macromolecule (e.g. protein, DNA) to high purity. The purified 
macromolecule is then crystallized. This process can be extremely problematic since 
protein crystals are difficult to grow, difficult to transport, and deteriorate rapidly. 
Several hundred must be grown in order to have one or two high-quality crystals. The 
crystals obtained are screened by exposing them to an X-ray beam to obtain a diffraction 
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pattern, which is processed to reveal information about the crystal packing symmetry and 
the size of the repeating unit in the crystals. Then the intensity of the diffraction pattern is 
used to determine the “structure factors” from which the electron density map is 
calculated. The quality of the map is improved using established refinement techniques 
so that a structure can be built using an available protein and/or nucleic acid sequence. 
The resulting structure from the map is refined so that it is in a very thermodynamically- 
favored and accurate conformation.  
 
 
 Principles of X-ray crystallography
 
In crystallography, crystals are used because X-ray diffraction from a single 
molecule is weak and would not be detected above the background noise. A crystal by 
definition is a homogeneous solid mass having a high degree of internal order with a 
specific overall chemical composition. Due to this internal order the scattered X-ray 
waves add up in phase, raising the signal to a measurable level. Thus, for the crystal to 
act as an amplifier it should be of the highest quality (Figure 1-5), which is measured in 
terms of diffraction quality. A good crystal has a clear diffraction pattern with  a good 
distribution of peak spots. X-rays have several characteristic wavelengths, and the one 
used for crystallography is called CuKα, which has a wavelength of 1.5418Å. This 
wavelength is used to study molecular structure because it is similar to the distance 
between two carbon atoms in a molecule. The consequence for an X-ray beam hitting a 
crystal is scattering of the X-ray beam as a function of incident and scattered angle, 
polarization and energy of wavelength, i.e. the result is the diffraction pattern, which is an 
array of spots from the electron density of all the atoms. The position and intensity of 
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Figure 1-5.  Composition of a protein crystal. Reprinted with permission from Randy, 
J.R. University of Cambridge. http://www-structmed.cimr.cam.ac.uk/Course/Overview/ 
Overview.html. Accessed April 6, 2007. 
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each spot is very important since it contains the information about the size of the unit cell 
and where the atoms lie with respect to each other in 3D space. The spots are two-
dimensional and represent a wave with amplitude and a relative phase. In reality, only the 
numbers of photons that are reflected from the crystal are measured and any information 
about the relative phase of the different diffractions is lost; this is called the  (phase 
problem). The problem arises because the X-rays start out with a dispersed phase, and 
deconvolution of the phase in the detector where the spots are collected is presently 
impossible. The diffraction pattern of a crystal depends on a number of factors. The size 
of the crystal is important because the scattering of the X-ray is directly proportional to 
the number of unit cells and how ordered they are in the crystal. The total number of unit 
cells in a crystal is directly proportional to the total volume of the crystal, so a simple 
doubling of the crystal dimensions will increase the diffraction by eight fold. The total 
number of unit cells also depends on the crystal size, which is directly correlated with the 
size of the protein, how many protein molecules are present in the asymmetric unit, and 
finally the symmetry within the crystal. 
To solve a new structure one must obtain the phase angle of the structure to be 
determined. As mentioned earlier, the phase angles are lost during the data collection 
process so they cannot be determined directly. However, they can be resolved indirectly 
through two approaches. The traditional, more conservative approach is to obtain a 
crystal similar, to the one being studied, except that a few atoms have either been added 
or replaced. If the replaced atoms are heavy, i.e. having a larger atomic number, they will 
disturb the diffraction pattern, a process called anomalous scattering. This perturbation 
may be enough to deduce the positions of the heavy atoms, and from knowing the 
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positions it may be possible to deduce the phase angles. This technique is called multiple 
isomorphous replacement (MIR). A similar technique called multiple-wavelength 
anomalous dispersion (MAD) can also be used. In MAD, data is collected from two 
different wavelengths corresponding to the peak and inflection of the heavy atoms 
present in the crystal. This is done by tuning the X-ray source. The difference in the 
perturbation of the diffraction pattern gives the same kind of information as in MIR. A 
more recent method is called molecular replacement (MR). MR takes advantage of a 
previously solved structure that is structurally or chemically similar to the structure being 
solved. The solved structure is used as a search model to guess the orientation and 
position of the molecules in the unit cell of the test structure. The phases thus obtained 
can be used to generate the electron density map. Finally, if the data generated from the 
native crystal is of very high resolution i.e. better than 1.6 Å or 160 picometers, the 
structure can be solved directly. 
The phase obtained is then used to build the initial model in the electron density 
map. The electron density map contains the entire peak at each of the atomic positions 
and more typically tubes of electron density of the atoms that are bonded together. This is 
because proteins are such dynamic molecules that the unit cells are not aligned properly 
in the crystal, which is very noticeable when finer details are examined. A detailed 
protein structure is dependent upon how many atoms can be resolved from one another. 
Thus, higher resolution is critical if finer details are required. 
The initial model built by fitting an individual molecule to the electron density is 
refined, taking into account the thermal motion of the atoms and the best fit to the 
observed diffraction data. The process of refining generates a new set of phases and a 
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new electron density map. This process of refining and model building is carried out until 
there is the highest possible correlation between the diffraction data and the model. The 
R-factor (residual or agreement factor) is simply the average functional error of the 
calculated amplitude to the observed amplitude. Amplitude is the magnitude or 
"intensity" of the X-ray waves. The final solved structure should have an R-factor in the 
range of 15% to 25%. 
 
 
 
 
Crystallization 
The first and most important rate-limiting step in macromolecular structure 
determination by X-ray crystallography is the crystallization of the macromolecule of 
interest. It is important to produce a crystal big enough (> 0.1 mm in its smallest 
dimension) in which the molecules are arranged in precise order so that the X-ray beam 
will be able to diffract and create a well-defined pattern of reflections that can be used for 
creating the electron density map. Crystallization involves the separation of 
macromolecules from the liquid phase into the solid phase; it involves two important 
processes; “nucleation” and “crystal growth”. Both these processes occur only in a 
supersaturated solution where the concentration of macromolecules is far beyond their 
equilibrium solubility value. Crystallization conditions are chosen to promote crystal 
formation as compared to random aggregation of the protein (referred to as precipitation). 
Nucleation in a solution occurs when there is a sufficiently elevated solute concentration 
in a particular region to form stable clusters of molecules. The stability of the clusters is 
determined by a variety of factors including the concentration, temperature and presence 
of contamination.  This process is very important since at this point of crystal growth, 
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atoms in the macromolecules are internally arranging in an ordered fashion. Nucleation is 
followed by either crystal growth or more nucleation, and this is dependent upon what the 
condition favors. The result of the crystallization trial might be a single crystal or 
multiple crystals that vary in size and shape.  Even if supersaturation is attained, the 
requirements for nucleation and crystal growth are different. At a high supersaturation 
level both nucleation and growth occurs; at a lower level only the growth of the crystal is 
seen. Supersaturation that facilitates both nucleation and crystal growth can be obtained 
by a number of ways, (1) cooling the protein solution, (2) reducing the solubility of the 
macromolecule by the addition of a second solvent, (3) increasing the concentration of 
the solvent, (4) increasing the protein concentration, (5) changing the pH (6) changing the 
crystallization technique, and (7) addition of an additive. Crystals grow until the solution 
is no longer at supersaturation and the solid-liquid equilibrium is reached. 
 
Methods for protein crystallization  
There are many methods for protein crystallization, such as vapor diffusion, batch 
crystallization and the dialysis method to name a few. The vapor diffusion method is by 
far the most effective and popular. This technique involves equilibration in a closed 
chamber of a drop containing the protein, protein/DNA complex, buffers and precipitants 
at a lower concentration insufficient to precipitate, with a much larger reservoir 
containing precipitant and a dehydrating agent. This equilibration supersaturates the 
protein in the drop by removing solvent, and if the condition is right, nucleation may 
occur (Weber, 1991). Vapor diffusion is a convenient method because it uses a small 
volume, set-up is straightforward, and the results of each experiment can be quickly 
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checked. Vapor diffusion can be done in either a hanging drop or a sitting drop. In the 
hanging drop method the protein drop is placed on a coverslip, which is then inverted and 
used to seal the reservoir in a linbro plate (Figure 1-6). The sitting drop method uses a 
much smaller sample than the hanging drop method. In the sitting drop method, the drop 
is placed on a depression in either a microbridge in a linbro plate or a glass plate and put 
into a closed system to equilibrate against a larger reservoir (Figure 1-6). In batch 
crystallization all components including protein, buffer, and precipitants are combined 
together as shown in Figure 1-6. In this method, supersaturation required for nucleation is 
achieved on mixing and, if the condition is right, nucleation may occur. Since 
supersaturation is achieved very rapidly in this method, a large number of nuclei may be 
rapidly formed which may lead to many small poor-quality crystals. Alternatively, rapid 
nucleation may begin with a select few crystals that grow slowly and form better 
diffracting crystals. 
In the dialysis method the concentration of the macromolecules remains constant, 
but due to diffusion, the solution composition is altered considerably (Figure 1-6). This 
method can be used for crystallization of protein at low and high ionic strength. This is a 
very versatile method of crystallization because the protein and other components can be 
maintained at a constant level while changing the pH and precipitant concentration. This 
technique can be employed for proteins known to have lower solubility at low ionic 
strength since, when the concentration of the ions are reduced, the macromolecules tend 
to stabilize themselves through interaction with other molecules (McPherson, 1990); this 
phenomenon is traditionally referred to as “salting in”. Depending on the availability of 
the protein, one of the following dialysis methods can be used; (1) equilibrium dialysis 
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Figure 1-6.  Different methods of protein crystallization. (A) hanging drop method, (B) 
sitting drop method, (C) dialysis method, and (D) batch method. Reprinted with 
permission from Airlie, J.M. University of Cambridge. http://www-structmed.cimr. 
cam.ac.uk/Course/Crystals/ Theory/methods.html. Accessed April 6, 2007. 
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with dialysis tubes, (2) equilibrium dialysis with micro-dialysis (3) and equilibrium 
dialysis with acrylamide plugs. 
 
 
 Screening methods 
 
A good crystal is identified through a process called screening. There are many 
factors, such as pH, temperature, precipitant, ionic strength, and mono and/or divalent 
ions  that influence crystallization.  Screening is a search within these variables for an 
optimum crystallization condition to obtain a good diffraction-quality crystal. There are 
many screening methods, including full factorial, incomplete factorial, random, and 
sparse matrix. In the full factorial method all the parameters are taken into consideration 
and sampled. The problem with this method is that it is time consuming, since it requires 
a large number of crystallization trials and involves a large amount of sample. In the 
incomplete factorial screening method, a small number of factors are chosen rationally 
and tested evenly and efficiently. The effect of each factor is scored and evaluated. The 
results obtained are used to restrict the search criteria for optimal crystal growth. This 
method is a powerful tool since it reduces the number of crystallization trials required to 
identify the different variables (Carter and Carter, 1979). Random screening is similar to 
incomplete factorial screening except that the parameters selected for screening are 
purely random. The most commonly used method of screening is the sparse matrix, 
which was designed by utilizing conditions that have worked previously for other 
macromolecules (Jancarik and Kim, 1991). 
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Optimization  
The conditions, which favor nucleation and crystallization are used for 
preliminary optimization. In this step the buffer, pH, precipitant, protein concentration, 
crystallization method and additives are compared with each other by always keeping one 
of the parameters constant and varying another. From these comparisons, the important 
parameter that reproducibly drives the nucleation, crystallization and reproducibility can 
be identified. The parameters identified from preliminary optimization are refined until 
an optimal crystallization condition is found. The goal of optimization of crystallization 
condition is to get a good diffraction-quality crystal independent of its size and 
morphology. 
If the outcome of the optimization does not yield a good crystal, then the best 
possible way to obtain a structure is to try the following; (1) a ligand protein complex; 
this can help because the binding of the ligand orders the region of the protein that bind it 
or the ligand may bring a subdomain of the structure together and reduce flexibility, 
changing the surface properties of the protein, or finally causing a conformational change 
in the protein, (2) different constructs; this strategy is based on constructing sequential N- 
and C-terminal truncations of the gene of interest so that during crystallization the 
flexible features of the protein are not present and (3) different protein species such as 
point mutants. 
 
 
 Data collection and processing 
 
The crystals once prepared are harvested and mounted for diffraction analysis, 
since the most important requirement is that the crystal diffracts to high resolution. The 
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diffraction quality of the crystal can be (1) no diffraction,  (2) weak diffraction to10 Å   
(3) promising diffraction 3.5-6 Å, and (4) good diffraction that is better than 2.8 Å. There 
are several methods for mounting, and one is to place the crystal in a drop of oil or 
cryoprotectant using a nylon loop, which is immediately flash frozen in liquid nitrogen. 
By freezing the crystal in cryoprotectants, the radiation damage incurred during data 
collection is greatly reduced. Freezing reduces the thermal motion within the crystal, 
which may give rise to a good diffracting crystal with better quality data. The harvested 
crystals are mounted on a diffractometer that is coupled to an X-ray generator, which can 
have a stationary anode (circa 2kW DC input), rotating anode (circa 14kW DC input) or a 
synchrotron (Figure 1-7). The crystals can be screened by either exposing the crystals in a 
mounted capillary tube at room temperature or exposing the cryo-mounted crystal in a 
stream of liquid N2 at 100K (Hope, 1990). The X-rays diffract by interacting with the 
electrons in the crystal, and the diffrrcation is recorded on a charge-coupled device 
detector, which is then scanned into a computer. 
Successive images are collected as the crystals are rotated within the X-ray beam. 
For determination a structure with atomic detail, high resolution data should be collected 
with a well ordered array of spots towards the edge of the diffraction image. A resolution 
of 3 Å is sufficient to detect amino-acid side chains in the electron density (Figure 1-8).  
The amount of data required for structure determination depends on several 
variables (1) crystallographic symmetry: Only 60° of diffraction data is sufficient if the 
crystal has a high crystal symmetry; (2) non-crystallographic symmetry (NCS) the 
amount of symmetry present in the asymmetric unit i.e. how many identical units are 
present. A dimeric protein might exhibit a high level of NCS, and a high quality structure 
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Figure 1-7.  X-ray diffraction experiment. Reprinted with permission from Bernhard, R. 
http://ruppweb.dyndns.org/ Accessed April 6, 2007. 
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Figure 1-8. Im ino-acid sidechain at 3Å 
resolution, the second and third panels show the same amino-acid at 2 and 1.2 Å. 
 
portance of resolution. The top panel shows an am
Reprinted with permission from Bernhard, R. http://ruppweb.dyndns.org/. Accessed April 
6, 2007. 
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can be obtained from an incomplete dataset because of the compensation by averaging, 
(3) availability of molecular replacement; If a related structure has already been solved 
and only gaps need to be filled in the final structure, then an incomplete dataset is 
sufficient for structure determination, and (4) the resolution limit required. The amount of 
diffraction data required to determine a structure increases exponentially with the 
resolution.  
The initial diffraction pattern analysis gives enough information on the spot 
spacing on the detector for the desired crystal to detector distance. This is important since 
the general appearance of the diffraction pattern is due to the crystal symmetry, whereas 
the spot is dependent only on the unit cell dimension. Variation in the intensities of each 
spot defines the structure, which is extracted during data processing. The crystal to 
detector distance is also used to determine the oscillation range for each exposure. 
Oscillation can be from as little as 0.25° to 2°. The total number of spots on the 
diffraction pattern is controlled by the oscillation range of the exposure. All these 
parameters are taken into consideration for collecting the maximum amount of data 
possible for each image and the onset of spot overlap. 
Data is processed mathematically by many different algorithms. The first and 
foremost step of data processing is to determine relatively accurately the unit cell 
dimension and the crystal system to which the data belongs. This part of the data is 
obtained from the first image and this determines what the subsequent crystal orientation 
should be. After a complete dataset is obtained, indexing (Kabsch, 1988) is done. Each 
spot in the diffraction pattern is given an index, which is assigned three integers h, k and 
l. Indexing is the process of calculating a prediction of what the diffraction image will 
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look like from the unit cell dimensions and orientation, and then comparing by fitting the 
real image with the predicted image. After indexing, the intensity of each spot has to be 
measured. Presently a program called DENZO (Otwinowski, 1997) performs both 
indexing and intensity measurement. For structure determination the collection of 
diffraction images in the dataset must be related to each other. However, when the data is 
collected, due to the change in the intensity of the synchtron beam in different frames, 
and due to the size variation in the crystal in different orientations the spot intensity 
varies with the amount of beam traversed. So, through a process called scaling, all the 
diffraction images within a dataset are processed in relation to each other. By monitoring 
the scaling process and its statistics, spots or whole images can be rejected or reprocessed 
to preserve the quality of the data. SCALEPACK is one of the widely used programs for 
scaling (Otwinowski, 1997).  The output file from SCALEPACK contains the index of 
each individual spot and its measured intensity; this data has to be listed in numerical 
order according to index, which is done by the CCP4 suite (CCP4, 1994)  
As mentioned earlier, the intensity of the spot is determined by the amplitude of 
the wave and the phase, the difference is expressed as an angle between them. The CCP4 
suite is one of several programs that can deduce the amplitude. From the amplitude and 
the phase, a key parameter called the structure factor can be deduced. The structure factor 
is a complex number that contains the amplitude and phase of a wave. From the structure 
factor the arrangement of the atoms in the unit cell can be calculated. To calculate the 
structure factor the phase angle and, as mentioned earlier, there is no method currently to 
deconvolute the data in the detector; this is called the phase problem. 
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 Phase angle determination 
 
There are several methods to get the phase angle; they may be classified as the 
heavy atom method, molecular replacement and direct phasing (Ab Initio).  
Heavy atoms are normally used where there are no closely-related structures 
available.  This is an experimental phasing method based on the perturbation of the 
structure and diffraction pattern caused by the heavy atom. The classical method is the 
isomorphous replacement method (MIR) (Dickerson, 1961; Otwinowski, 1991; 
Hengming, 1997). In MIR, a nearly identical crystal (isomorphous) to the test crystal is 
used and a few atoms are either replaced or added, mostly by adding heavy atoms. The 
electron in the heavy atom scatters the X-ray and significantly perturbs the diffraction 
pattern in phase with one another. Due to this, different atoms contribute to the scattering 
intensity and are directly proportional to the number of electrons present in the crystal. 
This technique requires two datasets: one native and a second heavy atom derivative 
dataset. The heavy atoms typically used are mercury, platinum or gold. By comparing the 
differences that arise between the native and heavy atom derivative and carrying out 
subsequent refinement (Terwilliger and Eisenberg, 1987) the positions of the heavy 
atoms can be deduced along with the amplitudes, the structure factor.  
Multiple wavelength anomalous dispersion (MAD) is a technique similar to MIR 
but one in which the wavelength of the X-ray is changed to cause anomalous scattering 
and/or perturbation from the heavy atom crystal. The information gathered is similar to 
MIR but presently MAD is the method of choice for solving protein structures because all 
the data can be obtained from a single crystal and the phase angle information obtained is 
more accurate than that from MIR (Hendrickson, 1991; Smith, 1991; Hendrickson, 
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1997). In MAD the heavy atoms electrons absorb X-rays of a particular wavelength and 
re-emit them after a delay, thereby inducing the shift in phase in all the reflections. This 
is known as the anomalous dispersion effect. This shift, when analyzed, can give the 
phase angle. The drawback of MAD is that it requires X-ray excitation at a very specific 
wavelength near the absorption edge of the heavy atom used, so it is necessary to use 
synchrotron radiation. The most poplar way to use MAD is to introduce seleno-
methionine (SeMet) in place of methionine residues in the protein (Ogata, 1998).  This 
method is popular because methionine naturally occurs in proteins at a level of about       
2%, and SeMet-substituted proteins are structurally isomorphous to the native protein. 
Furthermore, both prokaryotic and eukaryotic cells can be grown in media substituted 
with SeMet. The other experimental method of phase determination is a modification of 
MAD called single wavelength anomalous diffraction (SAD) (Wang, 1985). SAD 
phasing requires only a single dataset and is made up of (1) finding anomalous scatterers, 
(2) evaluating initial phases, and (3). phase improvement by density modification 
algorithms (Hauptman, 1982; La Fortelle, 1997; Cowtan, 1999; Langs et al., 1999; 
Terwilliger, 2000).  
Molecular replacement (MR) (Rossmann, 1990) is a technique, which is used 
when a closely-related structure is available. The structure has to be either chemically or 
structurally similar for it to be used in MR. In this technique the structure factors and the 
phase are calculated or borrowed from the already known coordinate files and applied to 
the data to be solved.  Before the phase can be applied to the test structure a process 
called, rotation function (Rossman, 1972; Rossmann, 1990) has to be performed.  In 
rotation function the model structure has to be placed in the unit cell in the same exact 
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position and orientation as the new protein molecule. The rotation function is followed by 
the translation function (Taylor, 1959; Fujinaga, 1987) which moves the repositioned 
data through the unit cell to fit the new molecule precisely. Once the model has been 
positioned through multiple refinements, the position and orientation is improved. After 
refinement (Brunger, 1992) the phases from the model structure are applied and, with the 
new amplitudes, the structure factor for the test data is calculated. The most commonly 
used program for MR is called AmoRe (Navaza, 1997).  The drawback of MR is that 
there is a severe bias towards the model, but MR is very useful for doing ligand-binding 
studies or studying molecules with small differences such as mutations. 
Ab Initio phasing can be done if there is a very high resolution dataset available. 
The cut-off for this type of phasing is data should be better than 1.6 Å or 160 picometers. 
The limiting factors for this method are data quality and processing power. 
 
 
 Calculation of electron density map, refinement and model building 
 
Once the initial phases have been obtained, an electron density map can be 
calculated. The map has the three dimensional contours into which the structure will be 
built. The quality of the map depends on the spacing of the unit cell edges. The map is 
used preliminarily to derive portions of the structure that will give rise to a new set of 
phases and a new electron density map. This process is repeated until an error term called 
R-free has stabilized to a satisfactory value. This process is called refinement (Brunger, 
1992). Through refinement, an electron density map of sufficient quality can be 
determined, and this map can be used for model building. Model building is presently 
done through a computer graphics program such as “O” which displays the map” (Jones 
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et al., 1991). Using the protein sequence, residues are inserted into the map to commence 
model building. Care is taken to minimize the energy of conformation by using a 
dictionary of data on bond length and angles within the constraints of the map. The 
structure that has been built is judged through the standard crystallographic R-factor, 
which is simply the average fractional error in the calculated amplitude compared to the 
observed amplitude. For a good structure, the R-factor should be in the range of 15% to 
25%. The final output file is usually in the format of a protein data bank, known as a  
PDB file. 
 
Validation 
At a given resolution, there are three to four parameters for each atom. These 
parameters describe the position and mobility of the atom. Due to the lack of enough 
data, diffraction data is usually supplanted with restraints on geometry, which maintains 
the bond length, angles and close contacts in a reasonable range. Therefore, with this 
information it is very easy to overfit the data; thereby disagreeing with the observed data. 
Usually this problem is circumvented by using only part of the data for refinement and 
then the rest of the data is used to verify how well the refinement has performed. This 
process is called cross-validation (Brunger, 1992). Another tool for validation is to use 
the Ramachandran plot, which defines the mainchain and side chain torsion angles. 
 
 
 Bacteriophage Mu
 
Mu is a temperate phage of Escherichia coli K-12 and other enteric bacteria 
(Paolozzi, 2006; Symonds, 1987).  The Mu genome encodes ~ 45 genes, which are 
 36 
  
 
necessary for the phage replication, growth, morphogenesis, DNA modification and cell 
lysis. Following entero-bacterial infection, depending on the environment, nutrition and 
host cell conditions, Mu can form a lysogen or enter a lytic mode of replication for 
production of progeny phage particles. The lytic cycle is tightly regulated by a 
transcriptional cascade, which is divided into early, middle, and late phases (Figure 1-9)  
(Stoddard and Howe, 1989; Marrs and Howe, 1990). Transcription from the early 
promoter (Pe) is entirely independent of replication and de novo protein synthesis. Host 
encoded RNAP is sufficient to carry out transcription from Pe  since Pe resembles the 
consensus promoter sequence. The middle operon regulator, Mor, is produced from the 
last gene in the early transcript (Mathee and Howe, 1990). Mor activates the middle 
promoter Pm, and C protein is encoded in the last gene of the middle transcript. The C 
protein activates transcription from the four late promoters Plys, PI, PP, and Pmom 
(Margolin et al., 1989).  
The middle and late promoters each have a –10 hexamer but lack a detectable –35 
hexamer (Margolin et al., 1989). These promoters have a Mor or C binding site just 
upstream of the –35 region and centered on – 43.5 (Chiang and Howe, 1993; 
Artsimovitch and Howe, 1996; Ramesh and Nagaraja, 1996; Sun et al., 1997). These 
properties are typical for promoters under positive regulation. Transcription from the 
middle and late promoters are catalyzed by the host-encoded RNAP containing σ70 
(Hattman et al., 1985; Margolin et al., 1989) and are dependent on DNA replication and 
de novo protein synthesis. A homology search with the amino-acid sequence of Mor 
identified the Mu late promoter activator C, bacterial regulator RdgB, and 12 proteins 
from other Mu-like prophages as sequence homologues (Kumaraswami et al., 2004).  
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Figure 1-9.  Transcriptional organization of bacteriophage Mu. The Mu genome is shown 
as a dark horizontal line above which the location of each Mu gene is given. The 
promoters and the direction in which they promote transcription are shown below the 
genome. The early (red) transcript encodes the Mor protein, which activates middle 
transcription (green). The middle transcript encodes the C protein, which activates late 
transcription (blue).  
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BLASTP alignment (Altschul et al., 1997) of Mor and C amino-acid sequences 
revealed that Mor and C share a high degree of amino-acid sequence similarity with each 
other, (38% identical amino- acids and 55% chemically similar amino-acids), but not 
with other known transcription activators (Figure 1-10). Thus, they identify a new family 
of transcription factors (Mathee and Howe, 1990) (Figure 1-10). Mor and C proteins form 
dimers in solution (Artsimovitch and Howe, 1996; Ramesh and Nagaraja, 1996) and bind 
an imperfect dyad-symmetry element. Mutational and biochemical analysis of Pm indicate 
that the –10 hexamer and the Mor binding regions are important for activation 
(Artsimovitch and Howe, 1996). These analyses also showed that the bases downstream 
of the Mor binding site have an important role in DNA distortion and a possible role in 
transcription activation. The AT- rich region just upstream of the Mor binding site binds 
the α-CTD and may function as an UP-like element (Artsimovitch and Howe, 1996; Ma 
and Howe, 2004). In vitro transcription assays have indicated that the C-terminal domains 
of both the alpha and sigma subunits of RNAP are required for transactivation of Pm by 
Mor. 
A working model as to how Mor activates transcription in Pm has been proposed. 
According to the model Mor binds to the promoter as a dimer, recruits the RNAP and 
interacts with both α and σ70 subunits leading to transcription initiation (Artsimovitch 
and Howe, 1996). 
The crystal structure of Mor identified certain structural components which 
participate in dimerization, DNA binding and transcription activation (Figure 1-11).  Mor 
has an N-terminal dimerization domain and a C-terminal HTH DNA-binding domain 
(Kumaraswami et al., 2004). The two N-terminal helices of two monomers 
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Figure 1-10.  Amino-acid sequence alignment of members of the Mor and C family of 
transcription activators. Based on the Mor crystal structure, the locations of secondary 
structures (alpha α and beta β) predicted for the family is indicated above the sequence. 
Letters on a black background represent identical amino-acids and those on the shaded 
grey background represent chemically similar residues. The dots above the sequence 
indicate a 10 amino-acid sequence interval. Reprinted with permission from 
Kumaraswami, M., Howe, M.M., and Park, H.W. (2004) Crystal structure of the Mor 
protein of bacteriophage Mu, a member of the Mor/C family of transcription activators. J 
Biol Chem 279: 16581-16590. 
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Figure 1-11.  Crystal structure of His-Mor. The ribbon illustration shows two individual 
Mor monomers (yellow and red) dimerizing using alpha helices one and two and two 
interacting beta strands. The DNA binding HTH motif is made up of helix three, four and 
five. Reprinted with permission from Kumaraswami, M., Howe, M.M., and Park, H.W. 
(2004) Crystal structure of the Mor protein of bacteriophage Mu, a member of the Mor/C 
family of transcription activators. J Biol Chem 279: 16581-16590. 
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intertwine with each other to form a single, central, dimerization domain. 
The two flanking HTH domains are proposed to bind to two adjacent major 
grooves. Since the predicted DNA binding residues of Mor are too far apart to fit into two 
adjacent major grooves, DNA binding may be associated with conformational changes in 
the Mor dimer and the DNA (Kumaraswami et al., 2004). Based on the Mor crystal 
structure and amino-acid alignment it has been predicted that C has a similar HTH DNA-
binding motif and dimerization motif (Kumaraswami et al., 2004) and that DNA binding 
by C may also involve conformational changes. 
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Chapter 2. Binding Specificity of Mu Transcription Activator C 
 
 
 Introduction
 
In transcriptional regulation, understanding the sequence-specific binding of the 
transcription regulator is quite important. Sequence specificity of a protein is the ability 
to recognize its cognate binding site in the presence of non-specific DNA. In addition, 
specificity has to be defined in terms of the number of base pairs and sequence required 
to define a unique binding site in the whole genome. The molecular mechanism of 
identifying the individual base pairs is primarily through complementary hydrogen-
bonding through the major and minor grooves of the DNA and appropriately positioned 
specific amino-acids in the DNA-binding motif of the protein (von Hippel and McGhee, 
1972; Luger et al., 1997; Luscombe et al., 2001). When recognition of DNA by a 
regulatory protein is not possible, secondary mechanisms like single vs double strand and 
DNA secondary structure (B form vs Z form ) comes into play. This secondary 
recognition is primarily influenced by base-pair composition, electrostatic potential and 
stereochemistry (von Hippel and Berg, 1986). This mechanism only gives the regional 
binding specificity and does not give any information about specific base-pair amino-acid 
specificity, which is mostly provided by hydrogen bonding interactions. Following 
sequence specific reading by the protein of the probable hydrogen bond donors and 
acceptors, the specificity is further influenced by the overall affinity of the protein to the 
specific site in the DNA. Since there is a detectable decrease in the affinity from the 
correct site to the incorrect sites with decreasing homology, a relative comparison of 
affinity can be made. This is important because if there is an increased occurrence of the 
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wrong site, which can compete for the free protein, the occupancy of the correct site will 
be reduced. It is important to understand that more sequence specific binding energy is 
lost for every wrong base-pair when compared to a consensus pair because at least one 
hydrogen bond is broken and not replaced, thus specificity may also be attributed to the 
unfavorable effect of incorrect contacts. 
In most regulatory proteins the main determinants of specificity are the 
combination of contributions from the correct and incorrect base pairs, and in many, such 
as the Lac repressor, in addition to specific binding, there is also a requirement for non- 
specific electrostatic interaction between the amino-acid sidechains and the DNA 
phosphate backbone (Winter et al., 1981). But in certain isomerization states of the Lac 
repressor, T4 DNA polymerase (Fairfield et al., 1983) and E. coli RNAP the binding 
mode will be predominantly or wholly from electrostatic interaction rather than specific 
sequence interaction. This is to facilitate the proteins “sliding” over the DNA backbone. 
When the protein interacts with the DNA, due to the flexible nature of both 
macromolecules, there is a high possibility of structural distortion to facilitate specific 
binding interactions within an energetically available conformation. Conformational 
changes in a complex are common; they may improve or degrade potential hydrogen 
bonding between the DNA and the protein. 
Temperate phage Mu (Symonds et al, 1987;  Paolozzi, 2006) must have a 
mechanism to determine when to have its prophage excise from the host DNA and 
become lytic. The lytic cycle is tightly regulated by a transcriptional cascade designated 
as early, middle and late. All the lytic genes are arranged left to right in the genome and 
the transcription proceeds in this direction. Most proteins required for the head and tail 
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morphogenesis are encoded from the late transcripts originating from the four late 
promoters Plys, PI, PP, and Pmom (Margolin et al., 1989). The C protein is directly 
responsible for activating transcription from these late promoters. In the well studied 
promoters, Plys and Pmom, transcription starts downstream of a conserved sequence 
(Hattman et al., 1985; Margolin et al., 1989). Bolker et al. (1989) confirmed the finding 
that the C protein binds to a conserved sequence just upstream and overlapping the –35 
region using MPE Fe(II) footprinting.  
To define the sequence required for activation Chiang and Howe (1993) first 
made sequential deletions of Plys, with the results suggesting that sequences upstream of –
60 and downstream of +8 were dispensable for promoter activity. Chiang and Howe 
(1993) also made point mutations in Plys which revealed that sequence from –50 to –35 
was required for C-dependent activation (Figure 2-1). In Pmom, experiments from the 
Hattman lab showed that the C target site was between –33 and –52 (Balke et al., 1992; 
Gindlesperger and Hattman, 1994; Sun et al., 1997). By comparing the four late 
promoters along with the results of the point mutations Chiang and Howe (1993) 
proposed that C recognizes an inverted hexa-nucleotide repeat separated by a tetra-
nucleotide spacer. In Pmom, footprinting analysis led to the development of a consensus 
sequence which contained an inverted tetra nucleotide repeat separated by a GC-rich 
spacer and, most importantly, these data revealed that C interacts asymmetrically with 
this conserved sequence 5’…TTAT-N6-ATAACC… 3’(Ramesh and Nagaraja, 1996).  
Mutational analysis done by Zhao (1999) within the C protein binding site 
revealed that mutations made in the symmetry elements generally reduced C binding, but 
the effect was more pronounced when the mutations were in the promoter-proximal  
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half of the dyad-symmetry. In contrast, when the point mutations in the distal half of Plys 
made the sequence more symmetrical to the proximal half, C binding increased with 
concomitant increased promoter activity (Chiang and Howe, 1993; Zhao, 1999). It was 
also found that mutations outside the dyad-symmetry element reduced C-dependent 
activation without affecting C binding. Interestingly, while selecting for increased in vivo 
DNA binding at Plys, Jiang (1999) made the distal half of Plys more symmetrical to the 
proximal half, resulting in a new C repressible promoter called Prep . On closer 
examination of Prep using gel-shift it was observed that C protein bound about twice as 
strongly at Prep as compared to wild- type Plys. This symmetrical C binding sequence 
5’…ATTATGACTCCATAAT… 3’ was called Psym. The goal of this project is to define 
the binding specificity of C with emphasis on optimization of the binding sequence. 
 
 
 Materials and methods
 
 
 
 Media, chemicals and enzymes  
MacConkey-lactose plates contained 40 g/L of MacConkey agar base and were 
supplemented with 0.5% lactose (Difco). Ampcillin (Sigma) and chloramphenicol 
(Sigma) were used at 50 and 34 μg/ml respectively. The G50 Probe QuantTM  Sephadex 
column was from GE Healthcare Bio-Sciences AB. Radiolabelled [γ-32P] ATP (3000 
Ci/mmol) was from Perkin Elmer Life Sciences, EcoRI, BamHI and T4 polynucleotide 
kinase were from New England Biolabs. All dNTPS were purchased from Promega. 
Acrylamide, bisacrylamide, tetramethylethylenediamine (TEMED) and ammonium 
persulfate (APS) were purchased from BioRad. The QIAquick spin purification kit was 
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from Qiagen. Automated DNA sequencing was performed by the Molecular Resource 
Center of The University of Tennessee Health Science Center. 
 
 
 Oligodeoxyribonucleotides 
 
Tables 2-1 and 2-2 include the oligodeoxyribonucleotides used in cloning and 
electro-mobility shift assays. Synthesis of the oligodeoxyribonucleotides was done by 
Integrated DNA Technologies, Inc (IDT). 
 
 Bacterial strains and plasmids  
Plasmids containing Psym mutant promoters (pKK) were constructed in strain MH 
13312 (mcrA ∆proAB-lac thi gyrA endA hsdR relR supE44 recA; F' (pro+ lacIQ1 ∆lacZY ) 
(Artsimovitch and Howe, 1996). The plasmid pLC1 is a promoter-less lacZ fusion 
cloning vector and a ΔlacY derivative of pRS415 Chiang and Howe (1993). Plasmid 
pZZ41 contains the Mu C gene under the control of a T7 promoter. It also contains a  
Table 2-1.  Oligodeoxyribonucleotides used for Psym promoter construction. 
 
Primer Sequence Comments 
KAR 2 CGGAATTCCCGCCGGTTATATTANN
ACTCNNTAATCC 
Top strand primer used in Psym to 
generate mutations at positions –47,   
–46,–41, –40; with 5' EcoRI site 
KAR 3 ACGGGATCCCCAATTCTCTGATGGC
AGT 
Bottom strand primer to complete 
synthesis of mutants with 5' BamHI 
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 Table 2-2.  Oligodeoxyribonucleotides used for EMSA. 
 
Primer Sequence Comments 
KAR 75 GTTATATTATGACTCCATAATCCCGC Psym 26-mer Top strand WT 
KAR 76 GCGGGATTATGGAGTCATAATATAAC Psym 26-mer Bottom strand WT 
KAR 77 CGGTTATATTATGACTCCATAATCCC
GCAC 
Psym 30-mer Top strand WT 
KAR 78 GTGCGGGATTATGGAGTCATAATATA
ACCG 
Psym 30-mer Bottom strand WT 
KAR 79 CGGTTCTATTATGACTCCATAATCCCG
CAC 
Psym 30-mer Top strand  –53 C 
KAR 80 GTGCGGGATTATGGAGTCATAATAGA
ACCG 
Psym 30-mer Bottom strand –53 C 
KAR 81 CGGTTTTATTATGACTCCATAATCCCG
CAC 
Psym 30-mer Top strand  –53 T 
KAR 82 GTGCGGGATTATGGAGTCATAATAAA
ACCG 
Psym 30-mer Bottom strand –53 T 
KAR 83 CGGTTGTATTATGACTCCATAATCCC
GCAC 
Psym 30-mer Top strand  –53 G 
KAR 84 GTGCGGGATTATGGAGTCATAATACA
ACCG 
Psym 30-mer Bottom strand –53 G
KAR 85 CGGTTACATTATGACTCCATAATCCC
GCAC 
Psym 30-mer Top strand  –52 C 
KAR 86 GTGCGGGATTATGGAGTCATAATGTA
ACCG 
Psym 30-mer Bottom strand –52 C 
KAR 87 CGGTTAAATTATGACTCCATAATCCC
GCAC 
Psym 30-mer Top strand  –52 A 
KAR 88 GTGCGGGATTATGGAGTCATAATTTA
ACCG 
Psym 30-mer Bottom strand –52 A
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Table 2-2  (continued).  
Primer Sequence Comments 
KAR 89 CGGTTAGATTATGACTCCATAATCCC
GCAC 
Psym 30-mer Top strand  –52 G 
KAR 90 GTGCGGGATTATGGAGTCATAATCT
AACCG 
Psym 30-mer Bottom strand –52 G
KAR 91 CGGTTATATTATGTCACCATAATCCC
GCAC 
Psym 30-mer with Plys IR Top 
strand   
KAR 92 GTGCGGGATTATGGTGACATAATAT
AACCG 
Psym 30-mer with Plys IR Bottom 
strand   
KAR 93 CGGTTATTTCCTGACTCCATAATCCC
GCAC 
Plys30-mer with Psym IR Top 
strand   
KAR 94 GTGCGGGATTATGGAGTCAGGAAAT
AACCG 
Plys30-mer with Psym IR  Bottom 
strand   
KAR 95 CGGTTATATTATAACTCCATAATCCC
GCAC 
Psym 30-mer Top strand  –46 A 
KAR 96 GTGCGGGATTATGGAGTTATAATAT
AACCG 
Psym 30-mer Bottom strand  –46 A
KAR 97 CGGTTATATTATGACTCGATAATCCC
GCAC 
Psym 30-mer Top strand  –41 G 
KAR 98 GTGCGGGATTATCGAGTCATAATAT
AACCG 
Psym 30-mer Bottom strand  –41 G
KAR 99 CGGTTATATTATGACTCAATAATCCC
GCAC 
Psym 30-mer Top strand  –41 A 
KAR 100 GTGCGGGATTATTGAGTCATAATATA
ACCG 
Psym 30-mer Bottom strand  –41 A
KAR 101 CGGTTATATTAAAACTCCATAATCCC
GCAC 
Psym 30-mer Top strand  –46 A    
–47 A 
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Primer Sequence Comments 
KAR 102 GTGCGGGATTATGGAGTTTTAATATA
ACCG 
Psym 30-mer Bottom strand  –46 A 
-40 A 
KAR 103 CGGTTATATTATAACTCCTTAATCCC
GCAC 
Psym 30-mer Top strand  –46 A       
–40T 
KAR 104 GTGCGGGATTAAGGAGTTATAATAT
AACCG 
Psym 30-mer Bottom strand  –46 A 
–40 T 
KAR 105 CGGTTATATTATTACTCGATAATCCC
GCAC 
Psym 30-mer Top strand  –46 T     
–41 G 
KAR 106 GTGCGGGATTATCGAGTAATAATAT
AACCG 
Psym 30-mer Bottom strand  –46 T 
–41 G 
KAR 107 CGGTTATATTATCACTCGATAATCCC
GCAC 
Psym 30-mer Top strand  –46 C     
–41 G 
KAR 108 GTGCGGGATTATCGAGTGATAATAT
AACCG 
Psym 30-mer Bottom strand  –46 C 
–41 G 
KAR 109 CGGTTATATTATGACTCCATAATCCC
CCAC 
Psym 30-mer Top strand  –32 C 
KAR 110 GTGGGGGATTATGGAGTCATAATAT
AACCG 
Psym 30-mer Bottom strand  –32 C
KAR 111 CGGTTATATTATGACTCCATAATCCC
ACAC 
Psym 30-mer Top strand  –32 A 
KAR 112 GTGTGGGATTATGGAGTCATAATAT
AACCG 
Psym 30-mer Bottom strand  –32 A
KAR 113 CGGTTATATTATGACTCCATAATCCC
TCAC 
Psym 30-mer Top strand  –32 T 
KAR 114 GTGAGGGATTATGGAGTCATAATAT
AACCG 
Psym 30-mer Bottom strand  –32 T
 
Table 2-2  (continued). 
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modified PlacUV5 operator and promoter called PlacSYN downstream from the T7 promoter 
in front of the Mu C gene (Zhao, 1999). 
Psym mutants 
Degenerate mutations were introduced in positions –47, –46, –41 and –40 using 
degenerate top strand primers. The top and bottom primers (Kar 2 and 3) included Psym 
sequence from–51 to –36 with EcoRI and BamHI restriction sites at the 5′ ends. The 
promoters fragments were made by using primers Kar 2 and Kar 3 with the Psym promoter 
in plasmid as template (MH 14714). The PCR products were purified using a QIAquick 
spin purification kit (Qiagen), digested with EcoRI and BamHI and cloned into 
corresponding EcoRI and BamHI sites in pLC1 in front of the promoter-less lacZ gene. 
The ligation mix was transformed into MH 16823 a derivative of MH13312 containing 
the pZZ41 plasmid. Competent cells were prepared by the CaCl2 method ( Mandel and 
Higa, 1970; Mandel et al., 1990). After transformation with the pZZ41 library, mixture 
was then plated onto LB plates containing appropriate ampicillin and chloramphenicol. 
The resulting clones were transferred onto three fresh MacConkey-lactose indicator 
plates with different IPTG concentration (33 μM, 100 μM and 300 μM), ampicillin and 
chloramphenicol (two-plasmid transcription activation assay system). The plates were 
incubated at 32° C and colony color development was recorded every 3 hrs after 12 hrs of 
incubation. The promoter activity of the mutants was determined by comparing the 
intensity and the timing of color development over the incubation period relative to the 
activity of wild-type Psym. The Figure 2-2 shows how the two-plasmid transcription 
activation assay system works. 
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Figure 2-2.  Two-plasmid transcription activation assay system. Expression of C protein 
occurs when IPTG releases the repression of PlacSYN. The expressed C then transactivates 
the Psym promoter. Transcription from the Psym promoter leads to the synthesis of β-
galactosidase from the lacZ gene. 
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Electrophoretic mobility shift assays  
The ability of C protein to bind mutant C-binding sites was tested by 
electrophoretic mobility shift assay (EMSA) or simply, band shift assay (Carey, 1991). A 
30-bp probe was generated by taking 100 ng of top or bottom strand oligonucleotide and 
end-labelling with γ-32P ATP (3000 Ci/mmol) with polynucleotide kinase buffer. The 
labeled oligos were then annealed with 300 to 500 ng of the complimentary bottom or top 
strand by placing the mixture in a 100° C heat block for 2 minutes and then switching off 
the block for it to cool to room temperature. The annealed probe was purified using a 
G50 Probe QuantTM  Sephadex column as per manufacturer’s recommendation. The 
purified labeled probe (100-150 cpm) was incubated at 25° C for 30 min with and without 
purified wild-type C in 20 μl of buffer C (25 mM Hepes, pH 7.0, 75 mM NaCl, 5% 
glycerol, 4.5 mM MgCl2, 1 mM EDTA, 10 mM DTT). After incubation, the binding 
reaction was loaded on to a 8% non-denaturing acrylamide gel in 1X TBE buffer (Tris 
Base, Boric acid and EDTA) and subjected to electrophoresis  for 2 to 3 hrs at 4° C at 
10V/cm. The gel was then blotted onto Whatman filter paper and exposed to Kodak 
BiomaxTM MR without screen at -70° C overnight. 
 
 
 
Results
Psym mutants 
 Degenerate primers were used to introduce mutations at positions –47, –46, –41 
and –40. The phenotype of each promoter mutant was estimated from its color 
development on MacConkey-lactose plates. The plate phenotype for representative 
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mutants was done at least thrice with Psym as wild-type control. Table 2-3 shows the plate 
phenotype for all the mutants. Candidates for further testing using a gel-shift assay were 
identified and grouped as (1) high activity mutants, (2) moderate activity mutants, and (3) 
mutants with no activity based on their plate phenotype. At position –47 comparison of 
the WT base in all four late promoters and the plate phenotype of these mutants show that 
–47 T was most preferred. Mutants with A or G at position –46 had greater activity than 
mutants with either G or C; this was also seen in all Mu late promoters. At –41, C was 
preferred in the mutants as it was in the natural Mu late promoters. At position –40, A 
was consistently preferred. Based on these preferences, Psym containing –47 T, –46 G or 
A, –41 C and –40 A should have good transcription activity, and this prediction was 
validated by a single mutant with high activity in the plate assay Table 2-3. 
 
 
 Gel-shift assays 
 
To obtain an optimized C-binding sequence and to test candidate mutations it was 
necessary first to determine a minimal probe length. Oligonucleotide probes of varying 
length containing Psym sequence were annealed and were used to test the influence of 
length on C binding (Figure 2-3). The assay revealed that probe length of less than 26 bp 
reduced C binding. Therefore, a 30-mer probe length was chosen since it gave optimal 
binding with minimal influence in C binding. The binding ability of the mutants was 
scored by visually comparing the shifted band with the wild-type promoter. A score of 
“++++” was given if there was partial shift at 1x WT C concentration and complete shift 
between 2x and 4x. A single 1x is the difference in C protein required to shift the DNA 
relative to the WT promoter. 
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  Table 2-3. Grouping analysis of mutant promoters with C. 
 
Genotype with high 
activitya 
Genotype with 
moderate activity Genotype with no detectable activity 
–47–46–41–40b –47–46–41–40 –47–46–41–40 –47–46–41–40 
T   A   C  A T   A   T  A T   T   G  A A   T   A  A 
 A   A   C  A G   A   T  A A   C   A  A 
 T   G   G  A T   A   C  T T   C   A  A 
 T   G   A  A T   G   T  T C   C   G  T 
 C   T   C  A A   A  A  A C    C   T  G 
  T   T   G  G A   C   A  T 
  T   A   A  G C   A   G  A 
  A   T   A  G C   T   G  T 
  T   T   A  C T   T   A  G 
  A   T   G  G T   T   C  T 
  T   A   G  C G   C   G  T 
  A   T   T  T T   C   G  A 
  G   T   T  T T   C   G  T 
  C   T   T  T T   C   G  C 
  A   G   A  T T   T   G  G 
  T   T   A  G T   A   T  G 
  T   T   A  C C   A   A  A 
  T   T   T  C G   A   A  T 
  G   T   A  T C   G   C  T 
  T   C  T  C G   T   T  A 
a In vivo transcription activity for each mutant promoter was determined by plate 
phenotyping. 
b The bases at position –47–46–41–40 on the top strand are listed. The wild-type bases 
for Plys, PI, PP, and Pmom are TGCA, AACA, AACA and TGAA respectively. 
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Figure 2-3. Gel-shift assay of Psym with varying DNA length. Annealed Psym probes were 
incubated with WT C protein [ 0 ng (-), 20 ng (1x), 40 ng (2x), 80 ng (4x), 200 ng (10x)]. 
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 Gel-shift was used to test C binding to all four natural Mu late promoters, Psym 
and mutant Psym promoters. For Psym there was almost a 20-30% shift at 20 ng and almost 
100% shift was seen at 80 ng. The gel-shift results and its summary for all the mutants 
tested are presented in Figure 2-4, Table 2-4, Figure 2-5, Figure 2-6, Figure 2-7, Figure 2-
8 and Figure 2-9. 
 Mutations that greatly influence C binding were restricted to the region between  
–51 and–36.  Mutations tested outside of this region had very little or no effect on C 
binding. For mutations flanking the inverted repeat spacer (IR) all mutations tested 
except –46 A reduced C binding. Mutations located within the 4-bp spacer had the most 
effect in C binding. By switching the IR between Psym and Plys, it was found that the Psym 
IR in the Plys context significantly reduced C binding. When Psym IR was changed at only 
one base (–43 or –45) rather than multiple bases, C binding was not reduced as 
significantly. Lastly, when the length of the IR spacer was changed either by insertion or  
deletion, C binding was completely abolished. 
 
 Discussion 
Previous studies with Plys involved site-directed mutagenesis, deletion mapping, 
footprinting and gel-shift analysis. Those assays were done to investigate C binding as 
well as C-dependent transcription activation. These previous studies involved full-length 
promoters and His-tagged C protein. The present study was done to extend and validate 
the previous binding analyses by using shorter C-binding sequences and WT-C protein. 
The binding assays in this study were aimed at primarily delineating the importance of 
the sequences within and flanking the IR spacer. The secondary aspect of this project was
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Figure 2-4. Gel-shift assay for Psym mutants altered at –47, –46, –41 and –40. Labeled 
wild-type and mutant Psym 30-mer probes were incubated with 0 ng (-), 20 ng (1x), 40 ng 
(2x), 80 ng (4x), 200 ng (10x) with WT C protein. The bases at positions –47, –46, –41 
and –40 are listed above. The wild-type bases are TGCA. 
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Table 2-4.  Summary of the relative binding efficiency of Psym and Psym mutants altered at 
–47, –46, –41 and –40.  
–47 –46 –41 –40 Binding Efficiency 
T G C A ++++ 
T A C A ++++ 
T G G A +++ 
T G A A ++ 
A A C A + 
T T G A + 
T C G A - 
T A C T - 
 
The binding abilities of the Psym mutants were scored as “+”, relative to wild-type binding 
of  “++++.” 
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Figure 2-6.  Gel-shift assay for IR spacer mutants. Labeled wild-type and mutant Psym 30-
merprobes were incubated with 0 ng (-), 20 ng (1x), 40 ng (2x), 80 ng (4x), 200 ng  (10x) 
with WT-C protein. The mutant bases at positions –43 and –45 are shown above. (A) 
Gel-shift of Psym with Plys IR and Plys with Psym IR, (B) and (C) Psym IR spacer mutants.  
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Figure 2-9.  Summary of the gel-shift assay results. The top strand of the C footprint 
region in Psym from –58 to –29 is shown on the top of the figure. The candidate mutants 
tested in the assay are listed at their respective positions below the Psym sequence. The 
symbol ‘▲’ refers to a deletion in the sequence and ‘▼’ refers to an insertion in the 
sequence.  The abbreviation “NA” refers to “no activity”. 
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to identify possible additional flanking sequences that influence C binding.  
In the present study, there is enough evidence suggesting that length of the C-
binding sequence is important for efficient C-binding. When the length of the C-binding 
sequence was gradually reduced from a 30-mer to 18-mer, C binding was also reduced 
even though the core sequences known to be required for binding were intact. This result 
suggests that the bases and phosphodiester backbone adjacent to the core sequences may 
be required for stabilizing the C : DNA interactions. 
The imperfect dyad-symmetrical C-binding site  (–36 to –51) was identified by 
extensive biochemical analyses. In these assays, single mutations at positions –52 or –53 
had little effect on C-binding (Zhao, 1999). But Mo (2004) found that both positions 
showed increased C binding if –53 and –52 had a T. In this study, a conclusion can be 
reached that for these positions no bases are particularly preferred for C binding. The 
possible explanation as to why differences were noticed in previous assays may be 
attributed to how the experiment was set up. It is known that C-binding to its DNA is pH 
dependent and both previous studies used an optimal and a sub-optimal pH for C-binding 
assays.  
Mutations in the sequences flanking the IR (–47, –46, –41, –40) in the present 
study confirmed and extended the previous results (Zhao, 1999) to show that symmetrical 
base pairs (T-A, –47/–40) and (G-C,–46/–41) are important binding of C. Gel-shift 
analysis of the seven candidate mutants isolated by plate phenotyping showed only one 
mutant having almost WT activity. This mutant has WT bases at all positions except –46 
A. Previously in gel-shift assays it was shown that –46 A is a down mutant. Therefore, it 
is not surprising that the present study did validate the previous study that the best    
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 binding site for C is a perfect inverted repeat. 
The most surprising mutants that completely abolished or greatly diminished C 
binding were in the IR spacer sequence found between the inverted repeats. By switching 
the Psym IR with Plys IR and vice-versa, a profound effect in C-binding was noticed. The 
binding effect was first thought to be a combined sequence effect since Plys was already 
known to bind C less effectively than Psym. So, to identify the effect of the spacer 
sequence, point mutants were generated at positions –43 and –45 of the Psym IR. Both 
mutations did not reduce C binding dramatically, which suggested that the two mutations 
in the IR might disrupt possible C : DNA backbone interactions or change the local DNA 
architecture, which may destabilize C binding. However, G or T insertion in the spacer 
(or) deletion of C or T within the IR spacer completely abolished C binding. This effect 
may be due to the repositioning of the major groove in relation to the dyad symmetry 
since it is known that the C-binding site needs to be centered on –43.5. By taking into 
account the previous data and the present data a possible consensus sequence can be 
derived with the following characteristics; (1) the dyad symmetry element should be 
perfectly symmetrical (2) the IR spacer length requirement is absolute. 
The next chapter will describe the results of C : Psym co-crystallization 
experiments done in order to obtain a three-dimensional structure which might reveal 
possible protein – DNA  interactions and any associated conformational changes. 
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 Chapter 3. Expression, Purification, Crystallization and Preliminary X-ray Analysis   
of C Protein Bound to Psym DNA∗
 
 
 Introduction 
 
Escherichia coli K-12 and other enteric bacteria are hosts for bacteriophage Mu. 
Mu is a temperate phage that randomly inserts its 39-kb double-stranded linear DNA into 
the host DNA and may enter a lysogenic or a lytic life cycle depending on the host 
environment. The lysogenic cycle is mainly under the control of the Mu c repressor 
protein. When repression is released, the phage starts replicating and proceeds through 
the lytic cycle. The lytic cycle is tightly controlled by a transcriptional cascade; early, 
middle and late (Goosen, 1987; Stoddard and Howe,1989; Marrs and Howe, 1990). Early 
transcription starts from Pe and does not require de novo protein synthesis or DNA 
replication. Middle transcription is dependent upon Mor, an activator protein expressed 
from the Mu early transcript (Stoddard and Howe, 1989; Mathee and Howe, 1990; Marrs 
and Howe, 1990). The middle transcript codes for the C protein, the activator of the four 
late promoters Plys, PI, PP, and Pmom. The C protein binds a dyad-symmetry element just 
upstream of the –35 region from –52 to –32 on all four late promoters (Margolin et al., 
1989; Sun et al., 1997; Zhao, 1999). It has been shown that a C dimer (Ramesh and 
Nagaraja, 1996; De et al., 1997; Zhao, 1999) is able to bind the dyad-symmetry element. 
The C protein (140 amino-acids, 16.5 kDa monomer) is a close homologue of the 
Mu Mor protein. Both proteins share high sequence similarity with each other (Figure    
                                                 
∗ Modified with permission. Shanmuganatham, K. K., Ravichandran, M., Howe, M. M., 
and Park, H.W. (2007). Crystallization and preliminary X-ray analysis of phage Mu 
activator protein C in a complex with promoter DNA. Acta Cryst.F 63, 620-623. 
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1-10, Chapter 1). Secondary structural analysis of Mor and C proteins using the algorithm 
of Dodd and Eagan (Dodd and Egan, 1987) revealed that both proteins contain a C-
terminal HTH DNA-binding domain (Mathee and Howe, 1990). The crystal structure of 
His-Mor revealed that a Mor monomer is made up of an N-terminal dimerization domain 
and a C-terminal HTH DNA-binding domain (Kumaraswami et al., 2004). Dimerization 
between the two monomers occurs by intertwining the N-terminal helices (Figure 1-10 
Chapter 1). The two flanking HTH DNA-binding domains are proposed to bind two 
adjacent major grooves. Since the predicted DNA-binding residues of Mor are too far 
apart to fit into two adjacent major grooves, DNA binding may be associated with a 
conformational change in the Mor dimer. Since no protein : DNA complex structure has 
been determined for either Mor or C protein, structural analysis of Mu C protein bound to 
a synthetic late promoter Psym (Jiang, 1999a) was undertaken. The binary complex 
structure will provide a direct test of the predicted amino-acid-DNA interactions and 
associated protein and DNA conformational changes that have been proposed for DNA-
bound Mor and C proteins, based on the structure of Mor in the absence of DNA 
(Kumaraswami et al., 2004). The objective of this study is to crystallize and solve the 
structure of the Mu C : DNA complex. 
 
 
 Materials and methods
 
 
 
 
Chemicals, enzymes and media  
Standard bacterial cell growth and protein over-expression were done in Luria-
Bertani (LB) medium (Sambrook et al, 1989) containing chloramphenicol (Cm) at 34 
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μg/ml. Chloramphenicol, EDTA, Hepes, tris base, glycine, dithiothreitol (DTT), 
magnesium chloride (MgCl2), sodium chloride (NaCl), sodium dodecyl sulphate (SDS), 
boric acid, M9 minimal media, amino-acids L-lysine, L-phenylalanine, L-threonine, L-
isoleucine, L-leucine, L-valine and L-selenomethionine were purchased from Sigma. 
Isopropyl-β–D-thiogalacto-pyranoside (IPTG) was obtained from American Bioorganics. 
Ready GelTM  precast gels, acrylamide, bisacrylamide, low molecular weight precision plus 
protein standard, Bio-SafeTM Coomassie, tetramethylethylenediamine (TEMED), 
ammonium persulfate (APS) and Bradford reagent were purchased from BioRad. 
Glycerol was obtained from Fisher Scientific. Prepacked Hi-Trap Heparin column, SP 
Sepharose Fast Flow (FF) resin, Phenyl Sepharose FF column, Superdex-75 26/60 and 
16/160 gel-filtration columns and G50 Probe QuantTM  Sephadex column were from GE 
Healthcare Bio-Sciences AB. YM30 ultrafiltration membranes and Amicon concentrators 
were from Amicon Bioseparation. Radiolabelled [γ-32P] ATP (3000 Ci/mmol) was from 
Perkin Elmer life sciences; T4 polynucleotide kinase was from Promega and New 
England Bioloab. The automated DNA sequencing was performed by the Molecular 
Resource Center of The University of Tennessee Health Science Center. Electrospray 
mass spectrometry was performed by the Hartwell center for Biotechnology and 
Bioinformatics of St. Jude Children’s Research Hospital. 
 
 
 Bacterial strains and plasmids 
 
Plasmid pZZ41 (Figure 3-1) containing the Mu C gene under the control of a T7 
promoter was constructed by (Zhao, 1999) for efficient protein expression. The bacterial 
strains used for protein expression is listed in Table 3-1. 
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Figure 3-1.  Circular plasmid map of pZZ41. Plasmid pZZ41 is a pACYC derivative 
containing the PT7 and PlacSYN promoters upstream of the C gene. 
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Table 3-1.  Bacterial strains. 
Strain Strain genotype Reference/ derivation 
JM109DE3 mcrA ∆proAB-lac thi gyrA endA hsdR relR supE44 recA; F' (tra∆36 lacIQ ∆lacM15 pro+) λDE3a 
Yanish-Perron et 
al., 1985 
MH13355 mcrA ∆proAB-lac thi gyrA endA hsdR relR supE44 recA; F' (pro+ lacIQ1 ∆lacZY); λDE3a 
Artsimovitch and 
Howe, 1996 
MH13312 mcrA ∆proAB-lac thi gyrA endA hsdR relR supE44 recA; F' (pro+ lacIQ1 ∆lacZY) 
Artsimovitch and 
Howe, 1996 
aλ DE3 is a derivative of λ D69 containing the T7 RNA polymerase gene under control of 
the IPTG-inducible PlacUV5; it also carries imm21 and ∆nin5 mutations. Yanisch-Perron, 
C., Vieira, J., and Messing, J. (1985) Improved M13 phage cloning vectors and host 
strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33: 103-119. 
Artsimovitch, I., and Howe, M.M. (1996) Transcription activation by the bacteriophage 
Mu Mor protein: analysis of promoter mutations in Pm identifies a new region required 
for promoter function. Nucleic Acids Res 24: 450-457. 
 
 
 
 
Oligodeoxyribonucleotides 
Table 3-2 includes the oligodeoxyribonucleotides used in electro-mobility shift 
assays (EMSA) and crystallization. Synthesis of the oligodeoxyribonucleotides was done 
by Integrated DNA Technologies, Inc. (IDT) on commercial nucleic acid synthesizers 
(Model ABI394) using phosphoramidite chemistry (Caruthers et al., 1983). 
 
 
 Crystallization 
 
The 24-well polystyrene Linbro plates for hanging and sitting drop methods, 
square siliconized coverslips, forceps, anodized cryo loop tools for crystal manipulation 
and sealing tapes were purchased from Hampton Research. Crystal screen II, Lite screen, 
PEG/Ion Screen and I Additive screen were purchased from Hampton Research. Wizard  
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Table 3-2.  Oligodeoxyribonucleotides used for EMSA and crystallization. 
Primer Sequence Comments 
KAR 12 ATTATGACTCCATAATCC Top strand Psym 18-mer  
KAR 13 GGATTATGGAGTCATAAT Bottom strand   Psym 18-mer 
KAR 14 TTCCTGTCACCATAATCC WT Plys 18-mer  
KAR 15 GGATTATGGTGACAGGAA Bottom strand   Plys 18-mer 
KAR 16 TTTTATTATGACTCCATAATCCCG Top strand primer from –55 to–32 of 
Psym 24-mer  
KAR 17 CGGGATTATGGAGTCATAATAAAA Bottom strand Psym 24-mer 
KAR 18 TTATTATGACTCCATAATCC Top strand primer from –53 to –34 
of Psym 20-mer  
KAR 19 GGATTATGGAGTCATAATAA Bottom strand Psym 20-mer  
KAR 20 ATTTCCTGTCACCATAATCC Top strand Plys 20-mer sequence 
from –53 to –34  
KAR 21 TAAAGGACAGTGGTATTAGG Bottom strand Plys 20-mer 
KAR 22 TTATTTCCTGTCACCATAATCCCG Top strand Plys 24-mer from –53 to –
32  
KAR 23 CGGGATTATGGTGACAGGAAATAA Bottom strand Plys 24-mer 
KAR 24 ATATTATGACTCCATAATCC Top strand Psym 20-mer from –53 to 
–34.  
KAR 25 GGATTATGGAGTCATAATAT Bottom strand Psym 20-mer  
KAR 26 TATATTATGACTCCATAATCCC Top strand Psym 22-mer from –54 to 
–33. 
KAR 27 GGGATTATGGAGTCATAATATA Bottom strand Psym 22-mer 
KAR 28 TTGTATTATGACTCCATAATCCCA Top strand Psym 24-mer with –53G 
mutation.  
KAR 29 TGGGATTATGGAGTCATAATACAA Bottom strand Psym 24-mer with    –
53 G mutation.  
KAR 30 TGTATTATGACTCCATAATCCC Top strand Psym 22-mer with –53G 
mutation 
KAR 31 GGGATTATGGAGTCATAATACA Bottom strand Psym 22-mer with –53 
G Mutation 
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Primer Sequence Comments 
KAR 32 GTATTATGACTCCATAATCC Top strand Psym 20-mer 
KAR 33 GGATTATGGAGTCATAATAC Bottom strand Psym 20-mer 
KAR 34 TATTATGACTCCATAATC Top strand Psym 18-mer 
KAR 35 GATTATGGAGTCATAATA Bottom strand Psym 18-mer  
KAR 36 GTATTATGACTCCATAATCCGG Top strand Psym 20 plus 2 base 
overlap at the 3′ end 
KAR 37 GGATTATGGAGTCATAATACCC Bottom strand Psym 20 plus 2 base 
overlap at the 3′ end 
KAR 61 GTATTATGACTCCATAATCCG Top strand Psym 21-mer i.e. 20 mer 
with 1 base overlap at the 3′ end. 
KAR 62 GGATTATGGAGTCATAATACC Bottom strand Psym 21-mer i.e. 20 
mer with 1 base overlap. 
KAR 63 AGATTATGATATCATAATCTG Psym 21-mer, symmetrical 
sequence with 1 base overlap at 
the 3′ end 
KAR 64 AGATTATGATATCATAATCTC Bottom strand Psym 21-mer, 
symmetrical sequence with 1 base 
overlap at the 3′ end 
KAR 75 GTTATATTATGACTCCATAATCCCGC Top strand Psym 26-mer 
KAR 76 GCGGGATTATGGAGTCATAATATAA
C 
Bottom strand Psym 26-mer 
KAR 77 CGGTTATATTATGACTCCATAATCCC
GCAC 
Top strand Psym 30-mer 
KAR 78 GTGCGGGATTATGGAGTCATAATAT
AACCG 
Bottom strand Psym 30-mer 
KAR 126 CGGTTATTTCCTGTCACCATAATCCC
GCAC 
Top strand Plys 30-mer 
KAR 127 GTGCGGGATTATGGTGACAGGAAAT
AACCG 
Bottom strand Plys 30-mer 
 
Table 3-2  (Continued). 
a The oligodeoxyribonucleotide sequences are written from 5’ to 3’. 
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Screen I and II were purchased from Emerald Biosciences, the customized screens SGC 
and Redwing were from the Structural Genomics Consortium SGC. Additional solutions 
for refinement were made from chemicals of minimum purity ACS grade and were stored 
in 4° C or room temperature based on their chemical properties and manufacturer’s 
recommendations. 
 
 
 Wild-type C protein production
 
 
 
 Expression and solubility test
 
The expression and solubility of the WT C protein produced from pZZ41 was 
tested as follows. Plasmid pZZ41 was freshly transformed into JM109DE3 and a single 
colony was inoculated into 10 ml of LB with chloramphenicol at 34 μg /ml and grown at    
37° C overnight. The next morning the cells were used to inoculate a 100 ml culture, 
which was grown at 37° C at 225 rpm until the OD600 reached 0.4 to 0.5. At this point a 
1ml sample was taken and kept on ice to serve as an un-induced control. The rest of the 
culture was induced with 1 mM IPTG. Every hour a 1ml sample was taken for use as an 
induced sample. After 3 hours, the uninduced and induced cell cultures were centrifuged 
at 6000 RCF (Sorvall GSA 6000), and the cell pellets were kept on ice before proceeding 
to cell lysis. The pellet was resuspended in 1 ml of lysis buffer. The resuspended cells 
were lysed by sonication on ice using continuous cycle (4 times X 3 min Duty cycle 40 
and Output control 50). The lysed cells were centrifuged at 6000 RCF for 30 min to 
separate the supernatant from the pellet. The pellets were resuspended in 1 ml of buffer 
C. Then 30 μl of the sonicated supernatant and the resuspended pellet were loaded on to 
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10-20 Ready GelTM precast gels and electrophoresed in 1X tris glycine buffer for one hr at 
10V/cm and then stained with Bio-SafeTM Coomassie dye. The expression of WT C was 
also tested by varying the induction temperature from 16 to 32° C, expressing the protein 
in different expression hosts and in different media, including Terrific broth (Tartof, 
1987) 
 
 Large-scale production 
Based on the results of the expression tests, large-scale production was done with 
8-20 liters of LB medium supplemented with 34 μg /ml chloramphenicol. One hundred 
milliliters of overnight culture were used to inoculate 800 ml of LB in a 2-liter flask. The 
cells were grown at 37° C shaking at 225 rpm until the OD600 reached 0.4 to 0.5. At this 
stage, protein expression was induced with 1 mM IPTG. After three hours of expression, 
the cells were harvested by centrifugation at 6000 RCF for 15 min (Sorvall GSA 6000); 
the pellets were either processed immediately or frozen in liquid nitrogen and stored at -
70° C. The final protein yield depended mainly on the OD and culture volume induced. 
 
Cell lysis  
 
Fresh or thawed cell pellets were resuspended in lysis buffer and the cells were 
lysed by using a Microfluidics microfluidizer HC-8000. The cell suspension was passed 
through the microfluidizer twice to promote efficient cell lysis. Once lysed the cell 
suspension was subjected to centrifugation at 20,000 RCF for 30 min at 4° C (Sorvall 
SS34) to remove cell debris. Aliquots of the supernatant and insoluble fraction were 
saved for further analysis. 
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 Chromatography 
 
Wild-type C and protein : DNA complexes were purified using fast performance 
liquid chromatography (FPLC) in an ÄKTA FPLC machine (GE Healthcare Bio-Sciences 
AB). All buffers used hereafter were degassed by stirring under a vacuum. The over-
expressed C protein was purified with a four-step chromatography procedure as described 
below. The composition of the protein buffer used for purification is listed in Table 3-3. 
 
 Heparin-sepharose affinity chromatography
 
Heparin is a sulphated polysaccharide that mimics the binding properties of DNA 
and can be used as a first step to purify DNA binding proteins. In addition, heparin has a 
high density charge on its surface, so it can also be used as an ion exchanger. Due to the 
latter property, the ionic strength of the buffer used should be low, and the pH should be 
near pH 7. 
The lysed samples were first filtered through a 0.45 μm filter to remove cell 
debris. This is very important because an unfiltered sample will clog the column. The 
column, a prepacked 5-ml Hi-trap heparin FF column (GE Healthcare Bio-Sciences AB) 
was equilibrated with 100 ml of Heparin buffer A before the samples were loaded. To 
ensure maximum binding of the samples loaded onto the column, the flow rate was 
adjusted to 2ml/min and the flow through (FT) was kept for analysis. Elution of the 
bound protein was done using a linear gradient from zero to 500 mM NaCl over a 200 ml 
volume with a flow rate of 2 ml/min, and 5 ml fractions were collected. C protein eluted 
over a range from 200 to 300 mM NaCl, with the peak elution about 250 mM NaCl. 
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Table 3-3.  Buffers for protein purification. 
 
Buffer  name Buffer composition 
Cell lysis buffer 25 mM Hepes, pH 7.0, 50 mM NaCl, 5% glycerol,          
1 mM MgCl2, 1 mM EDTA, 1 mM DTT 
Hi-Heparin affinity 
chromatography buffer A 
Heparin buffer A: 25 mM Hepes, pH 7.0, 50 mM NaCl,  
5% glycerol, 1 mM MgCl2, 1 mM EDTA, 1 mM DTT 
Hi-Heparin affinity 
chromatography buffer B 
25 mM Hepes, pH 7.0, 500 mM NaCl, 5% glycerol,        
1 mM MgCl2, 1 mM EDTA, 1 mM DTT 
SP-Sepharose Cation exchange 
chromatography buffer A 
25 mM Hepes, pH 7.0, 100 mM NaCl, 5% glycerol,        
1 mM MgCl2, 1 mM EDTA, 1 mM DTT 
SP-Sepharose Cation exchange 
chromatography buffer B 
25 mM Hepes, pH 7.0, 500 mM NaCl, 5% glycerol,        
1 mM MgCl2, 1 mM EDTA, 1 mM DTT 
Phenyl Sepharose Hydrophobic 
chromatography buffer A 
25 mM Hepes, pH 7.0, 1.5 M NaCl, 5% glycerol,             
1 mM MgCl2, 1 mM EDTA, 1 mM DTT 
Phenyl Sepharose Hydrophobic 
chromatography buffer A 
25 mM Hepes, pH 7.0, 0 mM NaCl, 5% glycerol,            
1 mM MgCl2, 1 mM EDTA, 1 mM DTT 
Gel-filtration buffer A for 
protein purification 
25 mM Hepes, pH 7.0, 150 mM NaCl, 5% glycerol,        
1 mM MgCl2, 1 mM EDTA, 10 mM DTT 
Gel-filtration buffer B for 
complex purification 
25 mM Hepes, pH 7.0, 75 mM NaCl, 5% glycerol,          
1 mM MgCl2, 1 mM EDTA, 10 mM DTT 
Buffer C 25 mM Hepes, pH 7.0, 75 mM NaCl, 5% glycerol,       
4.5 mM MgCl2, 1 mM EDTA, 10 mM DTT 
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 SP-sepharose cation exchange column
 
Ion exchange chromatography is based on the electrostatic properties of the 
protein that bind to the charged surface group on the resin. For efficient electrostatic 
binding the total ionic strength has to be low (~50 mM). The above eluted proteins 
fractions were pooled and diluted with C buffer without NaCl so that the final salt 
concentration was 100 mM. This step is crucial since a minimum concentration of 100 
mM NaCl is required for C to bind to the column. The sample was then loaded onto a 
pre-equilibrated open SP-Sepharose cation exchange column (50 ml). The flow-through 
was kept for gel analysis. For elution, a linear gradient of 100 to 500 mM NaCl over a 
200-ml volume was used with a flow rate of 5 ml/min and fraction volume of 5 ml.  The 
C protein eluted from 200 to 300 mM NaCl with the peak elution about 275 mM NaCl. 
 
 Phenyl-sepharose hydrophobic exchange column
Here separation of biomolecules is based on their hydrophobicity.  When the 
biomolecules in a polar solvent are applied to a hydrophobic matrix, they establish a 
strong interaction with it. Elution is done by gradually reducing the polarity of the 
solution. 
This step was used to remove some of the contaminating protein not removed 
through the previous two purification steps. The pooled SP-Sepharose fraction was 
diluted with 5 M NaCl so that the final salt concentration was 1.5 M NaCl. The diluted 
pooled samples were then loaded onto a pre-equilibrated the Phenyl-Sepharose FF 
hydrophobic column (5 ml) (GE Healthcare Bio-Sciences AB). This high salt 
concentration was required for the protein to bind the matrix. The bound protein was 
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eluted with a linear gradient of 1.5 M to 0 mM NaCl over 110 ml with a flow rate of 
2ml/min with a fraction volume of 5ml was used. C protein eluted from around 700 to 
150 mM NaCl. 
 
 Gel-filtration or size-exclusion chromatography
Gel-filtration chromatography (GFC) is based on the size of the protein and the 
sieving properties of the gel-filtration matrix. Usually the GFC matrix has an exclusion 
limit based on which proteins of different sizes can be separated. High molecular weight 
protein elutes first and the protein with the lowest molecular weight elutes last. 
Gel-filtration was used as a final polishing step and to exchange the protein buffer 
during C protein purification and for purification of the protein DNA complex. This 
procedure was done on both an analytical and preparative scale. Analytical runs were 
done with Superdex 75 16/60 (GE Healthcare Bio-Sciences AB) and preparative runs in 
Superdex 75 26/60(GE Healthcare Bio-Sciences AB). 
The pooled fractions from the hydrophobic separation step were first filtered 
through a 0.22 μM filter to remove protein aggregates and then loaded onto a column pre-
equilibrated with GF buffer A or B. Wild-type C usually migrates as a single peak of 32 
kDa (the calculated dimer mass is 33 kDa) whereas the purified C : DNA complex 
migrates around 47 kDa. 
The peak C fractions or C: DNA fractions were pooled and concentrated to 30 
mg/ml using YM30 Amicon concentrators at room temperature (Amicon Bioseparation, 
Bedford, Massachusetts, USA) and stored at –70°C. 
The purity of the purified protein was visually examined on a Ready GelTM  precast 
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gels stained with Bio-SafeTM Coomassie. The concentration of C protein and the C : DNA 
complex was measured by the Bradford method (Bradford, 1976).  
 
 Selenomethionine C protein production
The following modifications were introduced into the basic C protein expression 
protocol described above to incorporate selenomethionine (SeMet) into C protein during 
expression. This modification is based on the metabolic inhibition method described by 
Van Duyne et al. (1993). A single colony was inoculated into 150 ml of LB medium 
containing 34 μg/ml chloramphenicol and grown overnight at 37° C. The next day the 
cells were collected and resuspended in 2L M9 minimal medium (Symonds, 1987) with 
34 μg/ ml chloramphenicol and grown for another 12 hrs or overnight. This culture was 
used to seed 8 L of minimal medium and grown at 37° C. When the cells reached an 
OD600 of 0.6, the following amino-acids (all from Sigma) were added: 800 mg each of L-
lysine, L-phenylalanine, and L-threonine, as well as 400 mg each of L-isoleucine, L -
leucine, L-valine and L-selenomethionine. After the culture was shaken for 15 min, 
protein expression was induced by adding IPTG to a final concentration of 1 mM, and the 
culture was grown for 12 hr at 37° C. Cell lysis and purification of the SeMet C protein 
were performed as described above for wild-type C.  
Electrospray mass spectrometry (ESI-TOF) was used to confirm the incorporation 
of two SeMet residues in place of the two naturally occurring methionine residues in C 
protein. 
 
 88 
  
 
Electrophoretic mobility shift assays  
The ability of C to bind double-stranded DNA of different lengths and optimum 
binding conditions were determined by electrophoretic mobility shift assay (EMSA) 
(Carey, 1991).  One hundred nanograms of top or bottom stand oligonucleotides used for 
crystallization were end labeled with T4 polynucleotide kinase γ32 P ATP (3000 
Ci/mmol) in polynucleotide kinase buffer. The labeled oligos were then annealed with 
300 to 500 ng of the complementary bottom or top strand oligos by placing the mixture 
on a 100° C heat block for 2 min and then switching the block off to let it cool to room 
temperature. The annealed probes were purified using a G50 Probe QuantTM  Sephadex 
column as per the manufacturers recommendation. The purified labeled probes were 
incubated at 25° C for 30 min with and without purified wild-type C in 20 μl of buffer C. 
After incubation, the binding reaction was loaded on to a 8% non-denaturing acrylamide 
gel in 1X TBE buffer and subjected to electrophoresis for 2 to 3 hrs at 4° C at 10V/cm. 
The gel was the blotted onto Whatman filter paper and exposed to Kodak BiomaxTM MR 
without a screen at -70° C overnight. 
 
 
 
Preparation of C : DNA complex for crystallization
Oligonucleotides used for crystallization were obtained as separate top and 
bottom strands from IDT (Integrated DNA Technologies, Coralville, IA). Equimolar 
amounts of the top and bottom strand were dissolved in buffer C, mixed and annealed in 
a thermal cycler. Efficient annealing was achieved by first incubating the 
oligodeoxyribonucleotides at 5° C above the predicted Tm of an oligonucleotide for 5 min 
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and next at 5° C below the predicted Tm for another 5 min; then rapidly cooling to room 
temperature. 
Protein : DNA complexes were formed by mixing WT C protein with double 
stranded DNA in a 1:1 molar ratio of C dimer to DNA. The formed complex was purified 
by using a Superdex 75 26/60 size-exclusion column (GE Healthcare Bio-Sciences AB) 
pre-equilibrated with GF buffer B. After elution the purified complex was concentrated to 
25-30 mg/ml using YM30 Amicon concentrators at RT (Amicon Bioseparation, Bedford, 
MA ) and stored at -70° C. 
 
 Crystallization 
Crystallization trials with the complex were done by both the hanging and the 
sitting drop methods as described above. The concentrated C : DNA complex at 25-30 
mg/ml was centrifuged at 13,000 rpm for 5 min in a tabletop centrifuge to remove 
aggregates, precipitates and dust. Depending on the method used for crystallization, the 
amount of complex solution mixed with the reservoir solution was varied (1 μl: 1 μl for 
hanging drop and 0.5 μl: 0.5 μl for sitting drop). In case of the sitting drop method, the 
plates were sealed with sealing tape; in case the of hanging drop the wells were sealed 
with siliconized cover slips. 
Crystallization was attempted at different temperatures including 18° C, 22° C and 
37° C. During the first week of the crystallization trial, the trays were examined every 
day; later they were examined once or twice a week. Initial screens were done with 
commercial screens such as Wizard screenTM I & II (Emerald Bioscience), Crystal 
screenTM, Crystal screen TM lite, PEG/Ion screen (Hampton Research) and customized 
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screens SGC / Redwing (Structural Genomics Consortium SGC). Initial crystallization 
conditions were fine tuned using very methodical grid screening in which the primary 
precipitant, additives, pH, temperature and the length of the DNA used in C : DNA 
complexes were varied. 
 
 Screening, data collection and processing 
The crystals were mounted in cryo loops after transiently dipping in a cryo 
protectant and flash frozen in liquid nitrogen. The quality of the crystals obtained from 
different C : DNA complexes and conditions was determined by X-ray diffraction 
analysis at the home source by comparing the diffraction patterns as well as the resolution 
cutoff. The crystal that showed good pattern and resolution was refrozen in liquid 
nitrogen. A SeMet peak data set was collected from the using a CCD image plate detector 
with synchrotron radiation of wavelength 0.9791 Å at beam line 17ID of the Advanced 
Photon Source (Argonne National Laboratory, Chicago, U.S.A). The distance between 
the crystal and detector was 300 mm; a total of 360 oscillation images were recorded with 
exposure times of 10 seconds. The diffraction data was indexed, processed, and scaled 
with DENZO and SCALEPACK programs in the HKL package(Otwinowski, 1997). The 
positions of the two SeMet residues were determined by the SOLVE program 
(Terwilliger and Berendzen, 1996). Preliminary model building and refinement was done 
with program O (Jones et al., 1991)and REFMAC5 (CCP4, 1994). 
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 Results
 
Many protocols have been developed previously to express and purify C protein 
for structural studies (Nagaraja et al., 1988; Bolker et al., 1989; Gindlesperger and 
Hattman, 1994;  Ramesh et al., 1994). A N- terminal truncation version of C protein was 
expressed in E coli BL21DE3 as an insoluble pellet and purified from it using a high salt 
extraction procedure followed by a specific immuno-affinity chromatography. 
Additionally, protocols for small scale production of his-tagged C protein in E coli using 
the soluble C fraction have also been developed (Jiang, 1999; Mo, 2004). 
Nevertheless, purification of native C protein for structural studies; a prerequisite 
for structure determination of protein DNA complexes involving WTC and its cognate 
DNA have not been described to date; the results presented here is the first such 
procedure. In the following section protein purification from the soluble fraction, 
complex formation and first crystallization trials and data collection will be described. 
 
 Protein purification: wild-type C protein
The C gene which was cloned into pACYC expression vector was assayed for 
expression by transforming into JM109DE3.The C protein expresses very poorly with at 
most 1-2 mg per litre of culture and is expressed as 50% soluble and 50% insoluble 
(Figure 3-2). Since WT C is a DNA binding protein a Heparin affinity chromatography 
was used as the first capture step, for intermediate purification a cation exchange 
chromatography and a hydrophobic exchange chromatography was used. As a final 
purification and buffer exchange step, gel-filtration/size exclusion was used. 
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Figure 3-2.  Expression gel of C protein. After over-expression the C protein was 
visualized by SDS-PAGE (8-20%) stained with Bio SafeTM coomassie Blue R250. Lanes, 
UI uninduced, I 1hrs C protein expression after one hour IPTG induction, I 2hrs C protein 
expression after two hour IPTG induction, and low molecular weight protein marker. 
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After expression, the cells were either used right away or frozen in -70° C. When 
protein was to be purified the cell pellet were lysed by using a microfludizer in 200 to 
300 ml of C buffer and this process was repeated twice for effective cell lysis. Cell debris 
and the over expressed proteins were separated by centrifugation. The cell pellet and 
supernatant was kept in 4° C for subsequent SDS-PAGE analysis. 
The C protein and other DNA binding protein in the supernatant were isolated 
from the Heparin affinity column using fast performance liquid chromatography (FPLC). 
Since C protein has low binding kinetics with heparin the lysed sample had to be applied 
a couple of times with a low flow rate for optimum binding to the column. The bulk 
contaminants not removed from the Heparin affinity chromatography was removed using 
a cation exchange column and a hydrophobic column as described in the materials and 
methods The peak fractions from cation and hydrophobic columns were fractionated in 
5ml tubes and pooled in preparation for the next stage of purification. Since C protein 
from the hydrophobic column was eluted out using a huge salt gradient, the protein 
storage buffer was exchanged using a gel-filtration column (Figures 3-3 and 3-4). After 
GFC typically the purity was ~95% as visualized from SDS-PAGE. Freezing the protein 
even in its storage buffer for an extended period denatured the protein as shown by the 
presence of large amounts of precipitates after thawing the stored protein. The detailed 
purification procedure is as described in the materials and methods.  
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Figure 3-3.  WT C purification strategy I. (A) chromatographic elution profile of the      
hi-trap heparin run, (B) SDS-PAGE (8-20%) of the elution fraction of hi-trap heparin 
stained with Bio SafeTM coomassie, (C) chromatographic elution profile of the               
SP-sepharose, and (D) SDS-PAGE (8-20%) of the elution fraction of SP-sepharose 
stained with Bio SafeTM Coomassie.  
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Figure 3-4.  WT C purification strategy II. (A) chromatographic elution profile of Phenyl-
sepharose run, (B) SDS-PAGE (8-20%) of the elution fraction of Phenyl-sepharose 
stained with Bio SafeTM coomassie, (C) chromatographic elution profile of the GFC and 
(D) SDS-PAGE (8-20%) of the elution fraction of GFC stained with Bio SafeTM 
coomassie. 
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 Characterization of the purified WT C protein by SDS PAGE, gel-shift assay and 
ESI-TOF mass spectrometry 
The SDS-PAGE was used throughout the purification process to monitor the 
purity, molecular weight and the integrity of C (aggregation and degradation). After each 
FPLC column, representative sample from the pooled fractions were collected and 
examined on a SDS-PAGE (Figure 3-5). 
Molecular weight of the purified protein was obtained by Electrospray ionization 
(ESI)- time of flight (TOF) mass spectrometry (MS). The observed mass of 16515.14 da 
is the monomeric molecular weight of C (Figure 3-6). 
To test if the purification scheme affected the biological activity (binding) of C, 
electro-mobility shift assays (EMSA) was carried out. EMSA was done using a 40-mer 
Psym fragment (Figure 3-7). Samples containing C fractions were taken from each stage of 
purification and assayed for binding at 100, 400 and 800ng total protein concentration in 
a 20μl. binding reaction. The binding was carried out at RT for 20 min before 
electrophoresis. The C protein present in different fractions was able to shift almost the 
same amount of probes at a given concentration suggesting that the biological activity of 
C protein was not compromised during purification. 
 
 Protein purification: selenomethionine C protein
Induction and over-expression of selenomethionine C was done in E. coli 
JM109DE3 containing pT7-PlacSYN C expression plasmid. Selenomethionine 
incorporation into the expressed C protein and its purification was done as per protocol 
described in the materials and method section. Since the metabolic inhibition method was 
used to incorporate of selenomethionine into the C protein, the amount of protein 
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Figure 3-5. WT C purification. (A) SDS-PAGE (8-20%) stained with Bio SafeTM 
Coomassie Blue R250. Lanes are uninduced (UI), Induced (I), Supernatant (Sup), Pellet 
(P), Heparin I and II, SP-sepharose (SP), Phenyl-sepharose (Phe) and Gel-filtration 
column (GFC) Chromatographic elution profile of Phenyl-sepharose run, and (B) SDS-
PAGE (8-20%) of concentrated GFC fraction stained with Bio SafeTM coomassie  
 
 
 
 98 
  
 
  
Figure 3-6. WT C ESI-TOF. The ESI mass spec profile of purified C protein. The X-axis 
denotes the molecular weight (da) range and the Y –axis denotes the percent of the 
protein at a given molecular weight. The observed peak mass of 16515.14 da refers to 
one monomer of C. 
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Figure  3-7. Electro-mobilty shift assay of C protein presenting different chromatographic 
fractions. Psym 40-mer probes were incubated with different C fraction [100, 400 and 
800ng total protein] in 20μl C buffer pH 7.0 at RT for 20min and electrophrosed on 10% 
a native acrylamide gel. 
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expressed was less than two fold when compared to wild-type protein expression. The 
final purified SeMet C protein was approximately 90% pure as determined visually from 
SDS-PAGE. Molecular weight of the SeMet C was determined by Electrospray 
ionization (ESI)- time of flight (TOF) mass spectrometry (MS) (Figure 3-8). The 
observed mass of 16608.37 da is the molecular weight of a C monomer with two 
selenium atoms incorporated without any further modification (Figure 3-8). 
 
 
 Electrophoretic mobility shift assay 
  
Crystallization was to be attempted with GFC purified C : DNA complexes made 
from DNA of varying lengths and sequences. Thus, it was necessary to identify suitable 
binding conditions using gel-shifts in which the complexes were stable enough to 
withstand the harsh GFC environment. Parameters including, pH, salt, magnesium and 
varying DNA length and sequence were tried 
Gel-shifts done with varying pH showed that pH 7 and 8.0 gave maximum C 
binding whereas pH 5.0 and 6.0 had minimal effect in C binding (Figure 3-9). Since there 
was little difference between pH 7.0 and 8.0, pH 7.0 buffer, which is near the 
physiological pH was chosen for complex formation.   
Gel-shifts revealed that the C : DNA complex became unstable if the  salt (NaCl) 
concentration increased from 150mm to 250mM. Based on this assay, 75mM NaCl 
concentration was chosen, since GFC requires a slightly higher salt concentration to 
prevent nonspecific binding of protein or complex to the resin (Figure 3-10).  
In the gel-shift assays to test the effect of increasing magnesium concentration 
(Figure 3-11), it was found that there was no noticeable difference in the stability of the 
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Figure 3-8. Selenomethionine C ESI-TOF. The ESI mass spec profile of purified SeMet 
C protein. The X -axis denotes the molecular weight (da) range and the Y–axis denotes 
the percent of the protein at a given molecular weight. The peak observed mass of 
16608.97 da refers to difference of two selenomethionine incorporation to one monomer 
of C. 
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Figure 3-9.  Gel-shift assay with purified WT C in C buffer with different pH. Psym30-mer 
probes were prepared by annealing end labeled Kar77 with Kar 78. Purified annealed 
probes were incubated with WT C protein [0ng (-), 20ng (1x), 40ng (2x)] in 20μl C 
buffer with different pH at RT for 20min. Electrophoresis was done on 8% native 
acrylamide gel. The pH of the buffers used is listed on top. 
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Figure 3-10.  Gel-shift assay with purified WT C in C buffer with different NaCl 
concentration. Psym30-mer probes were prepared by annealing end labeled Kar 77 with 
Kar 78.  Purified annealed probes were incubated with WT C protein [0ng (-), 20ng (1x), 
40ng (2x)] in 20μl C buffer pH 7.0 at RT for 20min. Electrophoresis was done on 8% 
native acrylamide gel. The NaCl concentration in the buffer used is listed on top of each 
panel. 
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Figure 3-11.  Gel-shift assay with purified WT C in C buffer with different Mg2+ 
concentration. Psym30-merprobes were prepared by annealing end labeled Kar 77 with 
Kar 78. Purified annealed probes were incubated with WT C protein [0ng (-), 20ng (1x), 
40ng (2x)] in 20μl C buffer pH 7.0 at RT for 20min. Electrophoresis was done on 8% 
native acrylamide gel. The Mg2+ concentration in the buffer used is listed on top of each 
panel. 
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complex with regard to magnesium concentration. So a minimal concentration of 1mm 
MgCl2 was used in complex formation concentration since it has been suggested 
previously that Mg2+ may be important for C protein conformational changes (De et al., 
1998). 
To increase the probability of complex crystallization, Psym and Plys of varying 
length were to be tried. Since, multiple combinations in length were possible, a 
subpopulation of DNA was tested in gel-shift assays (Figure 3-12). The assay showed 
that C was able to bind a Psym 24-mer effectively but in Plys the length had to be around 30 
bp.   Binding and stability of the complex was significantly reduced when the length was 
reduced from 22-mer to 18-mer. Therefore for crystallization trials it was decided that a 
minimum of 18 bp and a maximum of 24 bp of DNA would be tested for both Psym and 
Plys. 
 
 Complex formation  
The GFC purification of Mu C: DNA complexes suggested that the stability of the 
complex was not compromised and could be used in crystallization trials. Additionally, 
purification showed that, the binding condition identified through gel-shift assay was 
optimum and the purified protein was functional. For complex formation, WT C or 
selenomethionine C (SeMet C) was used at a concentration of 20-30mg in 10-12ml 
binding volume, and the binding was carried out by slow addition of the annealed oligos 
to the protein. This was done to avoid high local concentration of the DNA and to prevent 
precipitation. The binding reaction was carried out for 20 minutes at RT before gel- 
filtration. All binary complexes used for crystallization were purified using a  
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Figure 3-12.  Gel-shift assay with purified WT C in C buffer with Psym and Plys probes of 
varying length. Psym30-mer probes were prepared by annealing end labeled Kar 77 with 
Kar 78. Purified annealed probes were incubated with WT C protein [ 0ng (-), 20ng (1x), 
40ng (2x) ] in 20μl C buffer pH 7.0 at RT for 20min. Electrophoresis was done on 8% 
native acrylamide gel. The Mg2+ concentration in the buffer used is listed on top of each 
panel. 
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gel-filtration column because, (1) to exchange the protein buffer with the complex buffer 
(25mM Hepes, pH 7.0, 75mM NaCl, 5% glycerol, 1mM MgCl2, 1mM EDTA, 10mM 
DTT), and (2) to separate the binary complex from free DNA and /or free protein. The 
amount of free DNA and/ or protein varied every time the complex was purified, this 
variation was largely seen when different protein preparations were used, and the amount 
of precipitation formed during complex formation.  
The C : DNA binary complex eluted out at the expected size of 46-49 kDa  
(Figure 3-13) Elution fraction were tested by SDS PAGE electrophoresis and Bradford 
assay for the presence of C protein. By comparing the shift in the GFC elution profile 
(Figure 3-14) as well as the shift in the UV absorbance value for the DNA, the DNA in 
the complex was identified as the binding DNA. The purified binary complex could be 
concentrated up to 30-35 mg/ml without much precipitation. 
 
 Crystallization of Mu C : DNA complex
Crystallization trial of the binary complex was initially done with WT C : DNA 
complex since SeMet C : DNA complex production was laborious and the purified 
complex yield extremely low. Binary complex crystallization was done with a wide 
assortment of Psym and Plys DNA, which varied in length and sequence. (Figure 3-15) 
Initial screenings were done with a 24-mer Psym  C complex at 20-30 mg/ml, using  sitting 
drop vapor diffusion method. Depending on the availability of the complex six to seven 
different commercial screens were used (1μl:1μl complex to reservoir with a total of 200-
500 drops /complex) in different incubation temperature (4° C,18° C, 28° C and 37° C) 
The screens used were Hampton Index & Index HTTM screen, Hampton Natrix screen, 
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Figure 3-13.  Gel-filtration chromatography of C: DNA complex. The final GFC elution 
profile after complex formation. The UV absorbance at 260 shown in the Y-axis 
confirmed the presence of DNA. 
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Figure 3-15.  Complete list of Psym and Plys DNA used for crystallization. The minimum 
DNA length used for crystallization was a 18-mer (green shade). This formed the core for 
the entire longer DNA used. The sequence for the 18-mer and the rest of the flanking 
sequence for Psym and Plys is shown on the top panel. The green dot next to the 20mer + 
2bp overlap was the sequence used with C protein which gave diffracting crystal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 113 
  
 
Hampton Lite screen, Hampton Crystal Screen I and II, Hampton Peg/Ion screen and 
Emerald wizard screen I and II. Micro crystals, which were birefringent were only seen in 
crystallization trials done at 37° C and 18° C. Crystallization trials done at lower 
temperature had only clear drop or precipitation. The microcrystals grew from many 
different conditions and the most promising condition was from Emerald wizard screen. 
These crystals crystallized rapidly having a hollow tubular shaped morphology 
surrounded by precipitates and protein skin. A similar condition also  from Emerald 
wizard screen was identified for a complex made from Psym20-mer plus 2 base overlap. 
This condition gave a drop full of sperulites within 24 hrs. Since complex production was 
a laborious task with minimal yield, it was decided to refine first the Psym24-mer complex 
since the crystals obtained were physically better looking micro-crystals. Refinement was 
started for this complex because the crystals were too small for X-ray crystallography 
analysis. The Figure 3-16. shows the various stage of refinement for this complex. At the 
end of refinement, these crystals were tested for diffraction using an in house X-ray 
source. A wide array of mounting techniques were used to test the crystals, including,(1) 
varying the cryoprotectant, (2) testing crystal of different dimensions, and (3) performing 
X-ray analysis at room temperature. These techniques revealed that the quality of the 
crystals was poor and cannot be improved any further.  
 Crystallization of the complex made from Psym20-mer plus 2 base overlap was 
then undertaken since earlier crystallization trials with this complex was giving 
sperulites. After several round of refinements the condition was optimized from 0.1 M Na 
Citrate pH 6.5 and 20% w/v PEG 3000, 18° C to 0.1 M Na Citrate pH 5.7, 14% w/v PEG 
3000 with additive Benzamidine HCl 8% w/v. The Figure 3-17 shows the  
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improvement of the crystals during various stages of refinement. The final crystal 
obtained was a fragile highly birefringent triangular plate like crystal. 
 The final refined crystals were tested for diffraction using an in house X-ray 
source and multiple datasets were collected from advance photon source (APS, Argonne 
National Laboratory). The resolution of the data collected was ~2.8 Å but due to the 
fragility of the crystals and twinning the data collected was very mosaic and could not be 
processed further. Since no more refinement could be done with the present condition it 
was decided that new condition/s had to be identified to improve the quality of the 
the crystals and thus the quality of the data. To identify new conditions crystallization 
trials was done in Structural Genomics Consortium (SGC, Toronto) using hanging and 
sitting drop method in 24 well as well as 96 well plates. Screening was done only with 
two customized in house screens called SGC and Redwing. Multiple conditions were 
obtained in which this complex crystallized and Figure 3-18 shows some of those 
conditions, which gave good quality crystals.  
The crystals which grew in 1.4 M ammonium sulfate 16% ethylene glycol pH 5.7 
gave better diffracting crystals with low mosacity when it was analyzed using the in 
house X-ray source. Multiple dataset were collected and processed but due to the lack of 
a structural homologue, the complex structure could not be solved by molecular 
replacement. So to get the phase angle information required to solve this complex 
structure a selenomethionine C: Psym20-mer plus 2 base complex was prepared and 
crystallized in the same condition (Figure 3-19)
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Figure 3-18.  Different crystallization condition identified for WT C Psym20-mer plus 2 
base overlap. (A) 1.5 M ammonium sulfate 15% glycerol pH 5.7, (B) 1 M ammonium 
sulfate 35% glycerol pH 5.7, 10 mm DTT, (C) 1.4 M ammonium sulfate 15% ethylene 
glycol pH 5.7, and (D) 1.4 M ammonium sulfate 16% ethylene glycol pH 5.7. 
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Figure 3-19. Co-crystallization of native C and selenomethionine C with Psym20-mer plus 
2 base overlap in 1.4 M ammonium sulfate 16% ethylene glycol pH 5.7. (A) native C : 
DNA co-crystals (B) Selenomethionine C : DNA co-crystals. 
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Screening, data collection and processing
A single crystal that diffracted to approximately 4Å at the home source was taken 
to 17ID beam-line of the Advanced Photon Source (Argonne National Laboratory, 
Chicago, U.S.A) A single wavelength SAD experiment was conducted using a CCD 
image plate detector; a fluorescence scan near the selenium edge was carried out to obtain 
the correct wavelength for data collection. A complete data set was collected at 
wavelength 0.9791. The distance between the crystal and detector was 300 mm and a 
total of 360 oscillation images were recorded with exposure times of 10 seconds (Figure 
3-20). 
The diffraction data was indexed, processed, and scaled with DENZO and 
SCALEPACK programs in the HKL package (Otwinowski, 1997). The SeMetC : DNA 
complex was crystallized in P43 spacegroup with unit cell parameter a= 68.9Å and 
c=187.6 and there were two copies of the complex present in asymmetric unit (Table     
3-4). Structure determination was based on the incorporation of the SeMet in the C 
protein and obtaining the phase angle using the single wavelength dataset by applying the 
SAD technique. The positions of the two SeMet residues were determined by the SOLVE 
program (Terwilliger and Berendzen, 1999). An electron density map at a resolution of 
3.1Å was calculated from the phases obtained and at this resolution a straight B form 
DNA was clearly visualized. To fit the DNA in the electron density map as a rigid body a 
blunt end DNA model the DNA used for crystallization (Psym 20 with 2 base overlap) was 
made using the model it server (Vlahovicek et al., 2003) http://www.icgeb.trieste.it/dna). 
This model was then used to fit the DNA in the electron density using the program 
“O”(Jones et al., 1991). Rigid body modification was then done using REFMAC5  
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Figure 3-20.  Diffraction image of SeMet C : DNA complex at 3.1 Å collected at 17ID of 
the Advanced Photon Source. 
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Table 3-4.  Diffraction data statistics of SeMet C : DNA complex crystals. 
 
Data set SeMet C : DNA Complex 
X-ray source  APS (Beamline 17ID) 
Wavelength 0.9791 Å 
Detector  CCD 
Crystal Parameters  
          Space Group P43 
          Unit cell Parameters  
                 a 68.9 Å 
                 c 187.6 Å 
 Data statistics  
          Resolution 3.1 Å 
          No. of unique reflections 15,849 
          Completeness (%) 99.7 (100.0) 
          Rsyma 0.073 (0.299) 
          Average I/σ (I) 14.7 (6.4) 
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(CCP4, 1994) which resulted in the reduction of the R value from ~65% to ~47%. Further 
refinement were hindered at this point since the model DNA was blunt ended and also 
only 21 bp out of 22 bp of DNA used was fitting in the unit cell. So to fit the modelled 
DNA in the electron density map it was split into two 10-mers. The split 10-mer DNA 
was superimposed in the electron density according to the pseudo dyad symmetry of the 
DNA and rigid body modification was done, but the R factor did not improve anymore. 
Since the resolution of the dataset was low and the phases obtained through SAD not 
accurate enough only the C-α polyalanine model for the protein could be built. 
 
 Discussion
 
Structural studies in C protein have been hampered due to its tendency to 
aggregate at high concentration and no one has been able to produce a functional protein 
at a high enough concentration. The present study describes for the first time in detail; (1) 
the over-expression and purification of milligram quantities of homogenous, functional C 
protein, (2) the crystallization of a C : DNA complex, and (3) preliminary structural 
information of how C protein interacts with the DNA. 
The C protein expression vector (pZZ41) used in this study was based on the T7 
based expression system(Studier et al., 1990) and was constructed by Zhao, 1999. This 
vector has a synthetic promoter/operator called PlacSYN downstream from the T7 promoter 
in front of the Mu C gene for efficient repression and to prevent leaky protein expression 
before induction. The efficient repression was found to be extremely important because 
leaky expression of C protein led to a high C concentration within the cell, which is toxic 
and prevented C over-expression when the gene was induced.  
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The expression host JM109 DE3 was the only T7 expression host found suitable 
for C over-expression. In other expression host like BL21DE3, C protein expressed in 
large quantities but all of them were insoluble. It is possible that a rapid rate of C 
expression will have resulted in misfolding causing the protein to accumulate in the 
insoluble fraction. It is possible that JM109 DE3 may have provided an optimum balance 
between expression and folding resulting in more than basal level of expression but in 
just enough quantities to be purified. To overcome this problem large culture volume was 
utilized for purification. 
The over-expressed C protein was found in both the soluble and insoluble 
fractions. Since the primary aim was to obtain a fully functional and properly folded C 
protein only the soluble fraction was utilized. The protocol used in this study is unique 
because it minimizes the time required to efficiently purify large quantities of functional 
C protein. This protocol avoids the use of dialysis between subsequent steps, which 
usually take a longtime, which in turn may affect the activity of the protein. This 
procedure utilized the heparin affinity chromatography as the first step to enrich the 
protein since C is a DNA-binding protein. This step enriched every DNA binding 
proteins present in the soluble fraction so a second cation exchange chromatography was 
used to remove some of the contaminating proteins. This step took advantage of 
electrostatic surface potential of C, which has many charged residues in its N-and C-
terminus. During the course of developing this purification scheme, it was found that C 
protein was very stable at high salt concentration so the hydrophobic interaction 
chromatography (HIC) was utilized. The HIC is important because it removed some 
major contaminating protein co-purifying with C. These contaminating proteins could not 
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be removed by other procedure like ROTOFOR and only HIC was able to remove most 
of them. Since HIC used a high salt extraction process and C protein was to be used for 
co-crystallization, size exclusion was utilized as the final step to do buffer exchange and 
to remove some high molecular contaminant. 
The functional activity of the purified protein during each purification step was 
assayed by gel-shift using a labeled Psym promoter fragments and specific binding of the 
protein was maintained throughout the purification scheme.  
The primary aim of this study was to crystallize the C protein with its cognate 
DNA thus the choice of the DNA used for crystallization became very important. 
Previous protein DNA co-crystallizations have shown that, precise length and 
composition of the oligonucleotides used for crystallization is the most critical variable 
that must be determined for every new protein. Therefore, I initially looked at the well-
characterized Mu late promoter Plys for crystallization, but previous successful co- 
crystallization mostly involved the use of symmetrical DNA binding sequence for 
dimeric protein like C, so I decided to use Psym. The Psym promoter has a perfect inverted 
symmetry between its binding sites and has a high affinity for C protein. The second 
critical variable for co-crystallization is the length of the DNA. In the crystal, the DNA 
has a strong tendency to stack ends to end, so a precise length of the DNA fragment and 
the nature of the stacking interactions determines the crystalline order and subsequently 
the unit cell size. Since the length of the DNA fragment is determined by the size of the 
minimal binding site necessary for tight complex formation, I began complex formation 
with a 18-mer, which is the minimal double stranded sequence required for C binding and 
progressively increased the length till it reached a 24-mer. To increase the probability of 
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end-to-end stacking of oligonucleotides within the crystal, I tried changing the 
composition of the DNA ends by adding a single or double complimentary overhanging 
bases in the 5′ end. 
A stable C : DNA complex  was a pre-requisite for successful co-crystallization. 
This was achieved by purification the complex after it was made using size exclusion 
chromatography. This procedure is efficient in removing unbound protein or DNA that 
might hinder crystallization. A successful complex purification was also suggestive of a 
very stable complex formation with the expected stoichometry. 
Crystallization of the complex was done in both hanging and sitting drop method 
involving many different conditions. The appropriate crystal for structure analysis was 
identified through a series of screening. 
The preliminary complex structure of the C protein bound to the Psym promoter is 
the first ever for C protein as well as for the proteins of the Mor/ C family of transcription 
factors. The preliminary Cα- polyalanine main chain model reveals that C is a dimer and 
has a HTH motif in the C terminus. However, due to the lack of resolution the critical 
protein-DNA interactions, side chain contacts and C dimerization interface could not be 
visualized. The most interesting and bizarre find in the complex structure pertains to how 
C is bound to the major groove. In the crystal structure, the two symmetrical sites in the 
DNA is occupied by two C dimers and not one (Figure 3-21). This is a complete first as 
to how a dimeric protein binds its symmetrical binding site. Since there is no precedent 
for this mode of binding coupled with the low resolution of the structure, interpretation of 
the present structure is difficult. However, few rational hypotheses can explain as to why 
C follows this mode of DNA interactions. (1) Mor protein is closest homologue of C 
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Figure 3-21. Cα-Polyalanine main chain model of C : DNA complex structure. The 
structure reveals that two dimer of C bind two subsequent major grooves in the same 
phase. C interacts with DNA using HTH from two different monomers of two different C 
dimer. 
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protein. The HTH motif of the Mor when compared to the C HTH, look structurally 
identical (Figure 3-22). In addition, Mor HTH is structurally very similar to the Trp R 
HTH. In Trp R, it is shown that, at a low concentration, a single dimer binds to its 
operator site and if the concentration of the protein is increased, a second dimer may 
bind. By cautiously extrapolating this data we can hypothesize that at a high 
concentration like that used in crystallization there will be sufficient competition for the 
binding sites that two different dimer may bind subsequent major groove, (2) In the 
present study, I have used a perfect symmetrical sequence within the C binding area. This 
symmetry may cause the protein to bind with the same affinity and not discriminate two 
different dimer molecules when compared to an asymmetric sequence like Plys were if 
one C dimer bind the stronger proximal half the distal half may favor binding the C dimer 
already bound to proximal half in-order to stabilize the interaction. or the roundabout is 
the second C dimer cannot bind the weaker distal half  since one half of the symmetry is 
already occupied, (3) In gel-shift assays done by (De et al., 1997) using a mixture of C 
and a protein A-C fusion, it was shown that there is a possibility that a tetramer could 
bind. But in the assay no appropriate molecular weight was used to substantiate that, a 
tetramer could bind. Subsequent gel-shift and footprinting studies done by Sun and 
Hattman (1998) showed that C exhibited strong co-operativity in binding consistent with 
the binding of a tetramer,(4) The present structure may be a intermediate stage and 
crystallization may have only captured a snapshot of the whole DNA binding process. (5) 
The last hypotheses is that this might be nothing but an artifact of crystallization. 
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Figure 3-22. Comparison of C and Mor HTH motif. The ribbon figure shows structural 
similarity of the C and Mor HTH. The bottom panel shows the primary sequence 
alignment of Mor and C protein along with their secondary structure prediction based on 
Mor structure. The alignment shows the chemically identical (black shades) or similar 
amino-acids (grey shades) in Mor and C protein. 
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 Chapter 4. General Discussion
 
 
This chapter recapitulates the findings from the studies described in this work and 
recommends ideas for further research to understand the binding specificity and mode of 
C : DNA interactions. 
 
 
 Major findings
 
 
 
Binding specificity of Mu transcription activator C  
Transcription from the late promoters requires the activator protein C. The C 
protein binds the promoter in as a site-specific manner. Of the late promoters, Plys and 
Pmom have been studied in detail. In Plys the C-binding site is an imperfect dyad symmetry 
extending from –51 to –36. The binding site consists of two imperfect hexamer repeat 
(proximal and distal, 5’…TTCCTGTCACCATAAT…3’) separated by a four base 
spacer. Mutational analysis within the binding site showed that mutation in the distal half 
reduced C binding to varying degrees; whereas mutation in the proximal half caused 
severe C binding defect (Zhao, 1999). A strong C binding site (Psym) was developed from 
Plys were the hexamer of the distal half-site perfectly matched the wild type proximal 
half-site and separated by a four base spacer (5’…ATTATGACTCCATAAT…3’) (Jiang, 
1999).  Gel-shift experiments done with only the C–binding sequence from Psym promoter 
have demonstrated that in addition core- binding sequences, flanking sequences from –58 
to –52 and  -36 to –29 are required for C to stabilize its interactions with the core- 
binding sequences. It addition the analysis also showed that positions –52, -53 and –32 do 
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not influence the C-binding specificity. In Pmom genetic and biochemical analysis have 
shown that C bind Pmom asymmetrically and based on these analyses a consensus binding 
sequence for C was developed (5’…TTAT…N6…ATAACC…3’) (Gindlesperger and 
Hattman, 1994; Ramesh and Nagaraja, 1996; Sun et al., 1997). Curiously, the consensus 
sequence developed from Pmom has a six base spacer and whose contribution to C-binding 
was deemed minimal. However, in this study it is shown if the spacer length is not a rigid 
four base pair C-binding is completely abolished.  Additionally I have shown that the 
bases flanking the IR spacer (–47, –46, –41 and –40) should be a symmetrical pair (–47 T 
and –40 A and  –46 G and –41 C) for efficient C-binding. By merging the data from the 
present study with the data already available a conclusion can be drawn about the C-
binding requirements and specificity; (1) A minimum length of 30 bp is required for 
efficient C-binding (2) within the 30 bp, the core binding site should be a perfect 
hexameric dyad symmetry and (3) The spacer between the hexamer should be no more or 
less than four bases. From the results of this study, I was able to derive information 
regarding C-binding specificity and compared it to the binding specificity proposed by 
Gindlesperger & Hattaman.  
 
 
Expression, purification, crystallization and preliminary X-ray analysis of C protein 
bound to Psym DNA 
 Previously, structural studies in C have been hampered due to the lack of a 
suitable protocol describing how to purify milligram quantities of soluble C protein. In 
this study, large quantities of functional C protein were purified to near homogeneity, 
crystallized it with Psym DNA and preliminary structural information of how C binds its 
DNA was derived. The wild-type C protein expressed in JM109DE3 was purified using a 
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four- step chromatography procedure. Each step in the protocol was incorporated to 
enrich the C protein, remove contaminant proteins, decrease aggregation and increase 
solubility. 
 Crystallization was performed with purified WT C : DNA complex from Psym and 
Plys which varied in sequence and length using various commercially available screens in 
two different crystallization methods (hanging and sitting drop).  Diffraction data was 
collected from a single crystal (0.1(L) x 0.1 (B) x 0.5 (H) μM), which was crystallized 
using the sitting drop method in 1.4 M ammonium sulfate 16% ethylene glycol pH 5.7. 
Due to the lack of a structural homologue to do molecular replacement (MR) a SeMet C : 
DNA complex was crystallized under the same WT condition and diffraction data was 
collected at 3.1 Å resolution.  The phase angles were obtained using SAD phasing. A 
preliminary Cα- polyalanine main chain model was built based on the available phase 
angle information. The preliminary structure shows the general architecture of the 
protein-DNA complex. In the complex, two C-dimers are interacting without 
conformational changes with two adjacent major grooves on one face of the C-binding 
site. This structure is not consistent to structures of other DNA binding dimeric proteins 
and conflicts the gel-shifts results in Chapter 2. Gel-shifts have shown that IR spacer 
deletion in Psym were detrimental to C binding which is suggestive that the binding defect 
will occur only if a single C dimer is occupying its binding site. If two dimers of C 
protein were binding independently there will not be any binding defect because the two 
C dimer molecules will be able to overcome the change in orientation of the binding sites 
caused by the deletion. Furthermore in the deletion gel-shifts a barely detectable level of 
binding was noticed which is suggestive that a single C dimer may be trying to  
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compensate for the change in orientation in the C binding site caused by deletion.  
Presently it is very hard to draw a conclusion if there are two C dimers per DNA 
or one dimer per DNA since there are considerable differences in how gel-shift and 
crystallography are done. In-order to facilitate C : DNA crystallization a symmetrical  C 
binding site (Psym) was used instead of wild-type Plys. In Plys the proximal C binding is a 
stronger binding site (Jiang, 1999) when compared to distal binding site and this 
arrangement of binding site may favor a stepwise binding in which a single C dimer may 
bind the stronger binding site first and through a series of conformational changes may 
bind the weak binding site thereby stabilizing the complex. Since Psym has two strong 
binding sites, two C dimers may bind the binding sites with the same binding affinity 
thereby preventing the second C molecule in the either dimer to bind as seen in the 
crystal structure. Additionally the type of binding seen in the complex crystal structure 
may not be seen in-vivo since in 2004, Mo found out that there is an UP like element just 
upstream of the C binding site which is required for α-CTD binding. If two C dimers are 
present as seen in the crystal structure α-CTD binding to its binding site may be 
physically hindered. This argument is validated by the footprinting assays done by Zhao 
(1999), who by changing the order of addition was able to show that a single C molecule 
may bind to its binding site first and then recruit the RNA polymerase.  
The present structure may not reflect of how C interacts with its cognate DNA 
invivo since there is no precedence for this mode of binding and the available 
biochemical evidence does not validate this structure. There a few possible explanations 
as to why we have the present structure (1) as mentioned in the introduction, in 
crystallography crystals can only be obtained if higher concentration of macromolecules 
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are used. In protein DNA complex crystallization, crystal formation is usually driven by 
either the protein or DNA and if either of the macromolecules are in higher concentration 
than others abnormal crystals may form due to physico chemical variations normally not 
seen invivo, (2) in-order to drive crystallization a symmetrical DNA was used instead of 
the wild-type and due to the presence of two strong binding site the step wise transition 
by binding the stronger site first and then binding the weaker side is prevented. Since 
both sites have high affinity for C proteins, protein molecules binding to either side 
cannot displace each other, this combined with the high concentration might favor 
trapping the macromolecules as seen in the crystal and (3) the present structure may be an 
artifact of crystallization. 
The present structure has raised numerous questions in addition to the question 
regarding the mode of interaction. Due to the poor resolution and phase angle problems 
only an initial polyalanine could be built, with no further information available of how 
certain amino-acids interact with each other as well as the DNA. Additionally, out of the 
22 bp of DNA used in the crystallization only 21 bp is visible in the structure. In addition, 
there is no enough information if the structure is made up of dimers of dimers or 
independent tetramer.  
Even though there is a lot of ambiguity with regard to the structure, this study has 
overcome substantial problems that were hindering structural studies in C and has taken a 
major step towards understanding the transcriptional activation mechanism of C.   
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Future directions  
The present study has not addressed certain key questions with regard to binding 
specificity and many questions needs to be addressed with regard to the preliminary C- 
DNA structure. For the purpose of discussion, I will only be suggesting few ideas, which 
might address these questions. 
 
 
 Estimation of dissociation constants (Kd)
 
It has been shown qualitatively that, Psym is a stronger binding promoter than Plys 
but quantitatively this has not been shown. By estimating the dissociation constant, the 
strength of binding (or affinity) between the DNA and the C protein can be measured. 
The dissociation constant can be measured by a number of ways but the easiest is by 
doing gel-shifts. In gel-shifts the dissociation constant can be obtained by (a) titration of a 
low concentration of standard amount of DNA with increasing quantities of C protein and  
(b) titration of a high concentration of DNA with increasing quantities of C protein. Both 
these methods involve measuring the amount of free and bound DNA using densitometry 
or phosphorimaging. In both methods, it is very important to measure accurately the 
protein and DNA concentrations. The dissociation constant obtained through this method 
is not absolute but can used in comparative studies involving Mu late promoters. 
 
Analytical ultracentrifugation (AUC) of C : DNA complex
The preliminary C-DNA crystal structure shows that two dimers of C are binding 
to a single binding site. Since there is no precedence for this mode of binding, further 
biochemical and biophysical investigations need to be done to validate the structure. 
 136 
  
 
Analytical ultra-centrifugation is one of the methods, which can be used to test the 
structure. Analytical ultra-centrifugation can do two different experiments. (1) 
sedimentation velocity experiment and (2) sedimentation equilibrium experiments These 
method can reveal (a) The native molecular mass. AUC is presently the best method to 
determine the native molecular weight of the protein accurately, (b) Stoichiometry. High 
quality AUC data can easily determine if the native protein is a monomer or a multimer, 
(c) Assembly models. The assembly of a protein complex (eg. C : DNA complex) can be 
calculated from the determined molecular mass of the protein and DNA. It is even 
possible to follow the assembly when the different partners are added to the mixture one 
by one. In addition, the binding of protein to a ligand like DNA can be analyzed using 
sedimentation velocity methods because the DNA and the protein differ greatly in their 
sedimentation coefficients, (d) Conformation & shape. The conformation of a protein and 
as well as its macromolecular interactions can be studied using the sedimentation and 
diffusion coefficients obtained from the sedimentation velocity experiment. The overall 
conformation and shape of the protein or the protein complex can be compared with the 
crystal structure to assess the applicability of these macromolecules in solution, and      
(e) Association. The sedimentation equilibrium method is a very sensitive method to 
study relatively weak associations constants (Ka).  
 
Crystallization of truncated C : DNA complex
The information available from the present C : DNA complex structure is very 
limited due to its low resolution. In order to understand how C recognizes it binding 
sequence a higher resolution structure is needed.  Resolution of the structure is mostly 
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dependent on the crystal quality. The crystal quality can be improved by changing many 
different variables either in the protein or in its ligand. During the course of C : DNA 
crystallization only the length and the sequence of the DNA used in the complex was 
varied. An alternative approach to improve the resolution is to use a modified or 
truncated C protein in crystallization. Truncation of a protein may substantially improve 
the quality of the crystal because the flexible region in the protein may interfere with 
proper crystal formation thereby reducing its quality. Drawback to this approach is to 
identify which terminus and how many residues to truncate. This problem can be 
overcome if regions important for protein functions have been identified or if a protein 
similar to the protein of interest has already been solved. The Mor protein is the closest 
homologue of C. In the crystal structure of Mor, 26 residues at the N terminus and 9 
residues at the C terminus are not visible (Kumaraswami et al., 2004). The absence of 
these residues in the crystal structure is suggestive that they are flexible and disordered. 
By comparing the primary amino-acid sequence of C with Mor the number of amino-acid 
that could be truncated in the N and C terminus can be identified. Since a number of N 
and C terminal truncation combinations are possible, a rational approach in truncation is 
needed. 
 
 Crystallization of C with modified DNA  
The quality of the crystal can be improved if better phase angles can be obtained. 
The phases angle for the present C : DNA complex was obtained through Single 
wavelength anomalous dispersion method (SAD). In SAD phasing a single wavelength is 
used to calculate the phases so there is phase ambiguity which may result in poor quality 
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structure. These ambiguities are not usually seen in structures solved with multi-
wavelength anomalous dispersion method (MAD) that uses two wavelengths to calculate 
the phase angles.  Due to the fragility of the C : DNA complex crystal heavy atom soaks 
needed for MAD phasing  could not be performed. To overcome this problem DNA in 
the complex offers a simple and direct way to incorporate heavy atoms for MAD phasing. 
Heavy atoms like bromine and iodine can be incorporated in the oligonucleotides during 
its synthesis. Typically, 5-bromo-deoxyuridine and 5-iodo-deoxyuridine are introduced as 
isomorphous substitutions for thymidine and 5-bromo-deoxycytosine and 5-iodo-
deoxycytosine as nearly isomorphous substitutions for deoxycytosine. The main 
drawback in using this approach is that the modified bases may interfere with protein 
binding. Therefore, before crystallization the modified oligos need to be tested for protein 
binding using gel-shift assay. 
.  
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